AXA/2025/FY/Earnings presentation: Difference between revisions
Migrate infobox: document_type -> document_category; add specific form as document_type |
doc_archive: publish snjra2xp9r |
||
| Line 4: | Line 4: | ||
| period = FY |
| period = FY |
||
| period_label = FY25 |
| period_label = FY25 |
||
| document_category |
| document_category = Earnings presentation |
||
| document_name = AXA Full Year 2025 Results Presentation |
|||
| publication_date = 2026-02-26 |
| publication_date = 2026-02-26 |
||
| language = English |
| language = English |
||
| pages = 49 |
| pages = 49 |
||
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf |
||
| summary_md = <!-- ARCHIVE_MD_LINK_HERE --> |
|||
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026. |
|||
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages). |
|||
| wide = yes |
|||
| document = Document:AXA/2025/FY/Earnings presentation |
|||
| doc_id = snjra2xp9r |
|||
}} |
}} |
||
''This article summarizes AXA's |
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).'' |
||
== Full Year 2025 Earnings Presentation == |
|||
== Front matter == |
|||
== Importantlegalinformationandcautionarystatementsconcerningforward-lookingstatementsandtheuseof non-gaapfinancialmeasures == |
|||
=== Full Year 2025 earnings presentation === |
|||
== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures == |
|||
* ''AXA Full Year 2025'' earnings presentation delivered on February 26, 2026 <sup>p. 1</sup> |
|||
{{chunk|doc=snjra2xp9r|c=1|p=2}} |
|||
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures === |
|||
====== Forward-looking statements and risks ====== |
|||
* |
* Certain statements in the document are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and non-historical information. |
||
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could". |
|||
* ''Expected UEPS growth'' for 2026 is provided as one-off guidance in the context of the final year of the Group's current strategic plan <sup>p. 2</sup>. |
|||
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] ("UEPS") growth for [[Definition:Year 2026|2026]] are forward-looking and provide one-off guidance for the last year of the Group's current strategic plan. |
|||
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>. |
|||
* These statements are based on Management's current views and intentions and are subject to change. |
|||
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>. |
|||
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially. |
|||
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>. |
|||
* Each forward-looking statement is valid only at the date of the presentation. |
|||
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>. |
|||
* Important factors, risks, and uncertainties affecting AXA's business and/or results are described in Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 (the "2024 Universal Registration Document"). |
|||
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations. |
|||
{{chunk|doc=snjra2xp9r|c=2|p=2}} |
|||
=== Table of contents === |
|||
====== Non-GAAP financial measures (APMs) ====== |
|||
* The presentation refers to non-GAAP financial measures, or alternative performance measures ("APMs"), used by Management to analyze operating trends, financial performance, and position. |
|||
* ''FY25 Highlights'' presented by Thomas Buberl, Group CEO <sup>p. 3, 4</sup> |
|||
* These APMs provide investors with additional information deemed useful and relevant by Management. |
|||
* ''FY25 Business Performance'' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3, 9</sup> |
|||
* Non-GAAP financial measures generally lack standardized meaning and may not be comparable to similarly labeled measures from other companies. |
|||
* ''FY25 Financial Performance'' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3, 13</sup> |
|||
* APMs should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS. |
|||
* "[[Definition:Underlying earnings|Underlying earnings]]", [[Definition:Underlying earnings per share|UEPS]] ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" are APMs as defined by ESMA's guidelines and the AMF's related position statement issued in 2015. |
|||
* AXA provides a reconciliation of APMs to the most closely related financial statement items (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ("AXA's 2025 Activity Report"), under the heading "USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES". |
|||
* Further information on non-GAAP financial measures is available in the Glossary of AXA's 2025 Activity Report. |
|||
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com). |
|||
{{chunk|doc=snjra2xp9r|c=3|p=2}} |
|||
== FY25 Highlights == |
|||
====== Financial statements audit ====== |
|||
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, [[Definition:Year 2026|2026]]. |
|||
* Section divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>. |
|||
* The financial statements are subject to completion of an audit procedure by AXA's statutory auditors. |
|||
{{chunk|doc=snjra2xp9r|c=4|p=2}} |
|||
=== Full Year 2025 | Excellent performance === |
|||
====== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures ====== |
|||
<div |
<div class="ed-chart-desc"> |
||
[Chart/image description:] |
|||
{| class="wikitable fintable" |
|||
A small blue square logo with the word "AXA" in white text, where the "X" is stylized with a red slash. |
|||
|+ Key financial highlights, FY25 <sup>p. 5</sup> |
|||
! style="text-align:left" | Metric |
|||
! class="col-m" style="text-align:right" | Value |
|||
|- |
|||
| style="text-align:left" | Revenues growth vs. FY24 |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Underlying EPS growth vs. FY24 |
|||
| style="text-align:right" | +8% |
|||
|- |
|||
| style="text-align:left" | Return on equity |
|||
| style="text-align:right" | 16% |
|||
|- |
|||
| style="text-align:left" | Solvency II ratio |
|||
| style="text-align:right" | 224% |
|||
|- |
|||
| style="text-align:left" | DPS growth |
|||
| style="text-align:right" | +8% |
|||
|- |
|||
| style="text-align:left" | Annual share buyback |
|||
| style="text-align:right" | EUR 1.25bn |
|||
|- |
|||
| style="text-align:left" | Underlying EPS outlook for 2026 |
|||
| style="text-align:right" | Upper end of 6%-8% target range |
|||
|} |
|||
</div> |
</div> |
||
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026 |
|||
{{chunk|doc=snjra2xp9r|c=5|p=3}} |
|||
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions |
|||
====== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Decorative teal corner bracket graphic (top-right area of the content region) |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=6|p=3}} |
|||
====== Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Decorative teal corner bracket graphic (bottom-left area of the content region) |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=7|p=3}} |
|||
====== FY25 presentation sections ====== |
|||
* [[Definition:Full year 2025|FY25]] Highlights are on page 04, presented by Thomas Buberl, Group CEO. |
|||
* FY25 Business Performance is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
|||
* FY25 Financial Performance is on page 13, presented by Alban de Mailly Nesle, Group CFO. |
|||
== 1 FY25 Highlights == |
|||
{{chunk|doc=snjra2xp9r|c=8|p=4}} |
|||
====== CEO statement ====== |
|||
* Thomas Buberl is the Group CEO. |
|||
=== Full Year 2025 | Excellent performance === |
|||
{{chunk|doc=snjra2xp9r|c=9|p=5}} |
|||
====== Financial performance and shareholder returns ====== |
|||
* Revenues +6% vs. [[Definition:Full year 2024|FY24]] |
|||
* Return on Equity (ROE) 16% in [[Definition:Full year 2025|FY25]] |
|||
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24 |
|||
* Solvency II ratio 224% in FY25 |
|||
* [[Definition:Dividend|Dividend]] Per Share (DPS) growth +8% |
|||
* Annual [[Definition:Share buyback|share buyback]] of EUR 1.25bn |
|||
* Confident to deliver underlying EPS growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]] |
|||
{{chunk|doc=snjra2xp9r|c=10|p=5}} |
|||
====== Full Year 2025 | Excellent performance ====== |
|||
{{fn note|1=1|2=Based on the dividend proposed by AXA’s Board of Directors on February 25, 2026 and subject to approval by the Shareholders’ Annual General Meeting to be held on April 30, 2026.}} |
|||
{{fn note|1=2|2=Following AXA’s Board of Directors’ approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.}} |
|||
=== Executing the plan on growth, margin and efficiency === |
=== Executing the plan on growth, margin and efficiency === |
||
{{chunk|doc=snjra2xp9r|c=11|p=6}} |
|||
<div style="overflow-x:auto"> |
|||
====== Executing the plan on growth, margin and efficiency ====== |
|||
{| class="wikitable fintable" |
|||
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup> |
|||
<div class="ed-chart-desc"> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
Bar chart showing [[Definition:Underlying earnings|Underlying earnings]] in Euro billion for [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- FY24: 8.1 (light blue bar) |
|||
! class="col-s" style="text-align:right" | Change (constant FX) |
|||
- FY25: 8.4 (dark blue bar) |
|||
! class="col-s" style="text-align:right" | Change (excluding AXA IM) |
|||
- Growth from FY24 to FY25 is labeled as +6%. |
|||
|- |
|||
- A callout box next to the FY25 bar states: +9% excluding [[Definition:AXA Investment Managers|AXA IM]]. |
|||
| style="text-align:left" | Underlying earnings |
|||
| style="text-align:right" | 8.1 |
|||
| style="text-align:right" | 8.4 |
|||
| style="text-align:right" | +6% |
|||
| style="text-align:right" | +9% |
|||
|} |
|||
</div> |
</div> |
||
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) |
|||
{{chunk|doc=snjra2xp9r|c=12|p=6}} |
|||
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency |
|||
====== Organic growth and profitability ====== |
|||
* Scaling the business: Continued investments in growth and technology |
|||
* Top line growth: +6%, balanced across lines |
|||
** P&C: +5% |
|||
** Life: +9% |
|||
** Health: +5% |
|||
* Record profitability achieved |
|||
* Margin expansion in P&C and L&H |
|||
* Efficiency improved |
|||
{{chunk|doc=snjra2xp9r|c=13|p=6}} |
|||
====== Business scaling and earnings ====== |
|||
* Continued investments in growth and technology |
|||
* Consistent earnings growth while enhancing reserve prudence |
* Consistent earnings growth while enhancing reserve prudence |
||
=== Diversified franchise, well positioned in an attractive industry === |
=== Diversified franchise, well positioned in an attractive industry === |
||
==== Secular trends fueling demand across businesses ==== |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=14|p=7}} |
|||
|+ Gross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup> |
|||
====== Secular trends fueling demand across businesses ====== |
|||
! style="text-align:left" | Segment |
|||
! class="col-s" style="text-align:right" | Share |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Life |
|||
A central donut chart showing the FY23 [[Definition:Gross written premiums|gross written premium]] split, excluding [[Definition:AXA Investment Managers|AXA IM]] and holdings. The chart is divided into five segments: |
|||
| style="text-align:right" | 33% |
|||
- Life: 33% |
|||
|- |
|||
- Health: 17% |
|||
| style="text-align:left" | Health |
|||
- Large & Specialty: 17% |
|||
| style="text-align:right" | 17% |
|||
- SME & Mid-market: 16% |
|||
|- |
|||
- Retail: 17% |
|||
| style="text-align:left" | Large & Specialty |
|||
The AXA logo is in the center of the donut. |
|||
| style="text-align:right" | 17% |
|||
To the left of the chart is the text: "Protection gaps and emerging corporate risks". |
|||
|- |
|||
To the right of the chart is the text: "Demographics driving demand for private retirement and healthcare". |
|||
| style="text-align:left" | Retail |
|||
| style="text-align:right" | 17% |
|||
|- |
|||
| style="text-align:left" | SME & Mid-market |
|||
| style="text-align:right" | 16% |
|||
|} |
|||
</div> |
</div> |
||
==== Our right to win ==== |
|||
* ''Secular trends'' fuel demand across businesses, driven by protection gaps and emerging corporate risks, as well as demographics driving demand for private retirement and healthcare |
|||
* ''Our right to win'' is supported by four strategic pillars: |
|||
{{chunk|doc=snjra2xp9r|c=15|p=7}} |
|||
** Leading brand & high customer NPS |
|||
====== Our right to win ====== |
|||
** Strong and diversified distribution |
|||
** Technical expertise to price & underwrite risks |
|||
<div class="ed-chart-desc"> |
|||
** Scale offering cost advantage |
|||
[Chart/image description:] |
|||
Four horizontal capsules, each containing a checkmark icon and a key strength: |
|||
- Leading brand & high customer NPS |
|||
- Strong and diversified distribution |
|||
- Technical expertise to price & underwrite risks |
|||
- Scale offering cost advantage |
|||
@@ORIG_0@@ |
|||
</div> |
|||
=== Laying the foundation for the next plan === |
=== Laying the foundation for the next plan === |
||
{{chunk|doc=snjra2xp9r|c=16|p=8}} |
|||
* ''Strategic pillars'' established to lay the foundation for the next plan: |
|||
====== Strategic initiatives ====== |
|||
** ''Clear tech'' and AI roadmap <sup>p. 8</sup> |
|||
** ''Driving efficiency'' across operations <sup>p. 8</sup> |
|||
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup> |
|||
** ''Building resilience'' across the business <sup>p. 8</sup> |
|||
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup> |
|||
* Clear tech and AI roadmap is driving efficiency. |
|||
== Business Performance == |
|||
* Enhancing capital allocation discipline. |
|||
=== Confidence in sustaining earnings growth === |
|||
=== FY25 business performance === |
|||
{{chunk|doc=snjra2xp9r|c=17|p=8}} |
|||
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>. |
|||
====== Building resilience ====== |
|||
* GIE_AXA_Internal is focused on building resilience. |
|||
=== Strong delivery across our businesses === |
|||
{{chunk|doc=snjra2xp9r|c=17|p=9|cont=1}} |
|||
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology. |
|||
* Guillaume Borie presented on [[Definition:Full year 2025|FY25]] Business Performance. |
|||
== Strong delivery across our businesses == |
|||
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>. |
|||
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=18|p=10}} |
|||
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>. |
|||
====== Gross written premiums & underlying earnings by geography ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1" class="wikitable" |
||
|- |
|||
|+ Gross written premiums and underlying earnings by region FY25 <sup>p. 10</sup> |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:right" | Gross written premiums |
||
! |
! style="text-align:right" | Underlying earnings |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | France<br/>(27% of total GWP{{fn ref|1}}) |
||
| |
| style="text-align:right" | +6%<br/>to €31bn |
||
| |
| style="text-align:right" | +7%<br/>to €2.2bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Europe<br/>(38% of total GWP{{fn ref|1}}) |
||
| |
| style="text-align:right" | +6%<br/>to €43bn |
||
| |
| style="text-align:right" | +9%<br/>to €3.5bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | AXA XL<br/>(17% of total GWP{{fn ref|1}}) |
||
| |
| style="text-align:right" | +4%<br/>to €19bn |
||
| |
| style="text-align:right" | +9%<br/>to €1.9bn |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Asia, Africa & EME-LATAM<br/>(18% of total GWP{{fn ref|1}}) |
||
| |
| style="text-align:right" | +13%<br/>to €20bn |
||
| |
| style="text-align:right" | +6%<br/>to €1.5bn |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=19|p=10}} |
|||
=== P&C | Strong margins, confidence in sustaining growth === |
|||
====== Strong delivery across our businesses ====== |
|||
<div class="ed-chart-desc"> |
|||
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>. |
|||
[Chart/image description:] |
|||
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>. |
|||
A visual representation of the table above, showing four business segments (France, Europe, AXA XL, Asia, Africa & EME-LATAM) with their respective [[Definition:Gross written premiums|GWP]] and [[Definition:Underlying earnings|Underlying earnings]] growth percentages and absolute values, each row accompanied by a blue checkmark icon on the right. |
|||
** AXA XL GWP includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>. |
|||
</div> |
|||
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>. |
|||
* ''Retail and SME & Mid-market'' strategic outlook: |
|||
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>. |
|||
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>. |
|||
* ''AXA XL (Large & Specialty)'' strategic outlook: |
|||
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>. |
|||
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>. |
|||
* ''Earnings drivers'' supporting performance: |
|||
** Continued progress on efficiency <sup>p. 11</sup>. |
|||
** Higher investment income <sup>p. 11</sup>. |
|||
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=20|p=10}} |
|||
=== L&H | Good momentum, well positioned to capture growth opportunities === |
|||
====== Strong delivery across our businesses ====== |
|||
{{fn note|1=1|2=1. FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}} |
|||
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>. |
|||
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>. |
|||
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>. |
|||
* ''Long-term business'' strategic priorities: |
|||
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>. |
|||
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>. |
|||
* ''Short-term business'' strategic priorities: |
|||
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>. |
|||
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>. |
|||
* ''Strategic levers'' for growth and efficiency: |
|||
** Focus on cost reduction <sup>p. 12</sup>. |
|||
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>. |
|||
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>. |
|||
== P&C | Strong margins, confidence in sustaining growth == |
|||
== Financial Performance == |
|||
{{chunk|doc=snjra2xp9r|c=21|p=11}} |
|||
=== FY25 financial performance === |
|||
====== P&C | Strong margins, confidence in sustaining growth ====== |
|||
<div class="ed-chart-desc"> |
|||
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup> |
|||
[Chart/image description:] |
|||
A donut chart titled "[[Definition:Gross written premiums|GWP]]" with a central value of "€58bn". The chart is divided into three segments: |
|||
- "Retail" (light blue, largest segment) |
|||
- "SME & Mid-market" (medium blue, second largest) |
|||
- "AXA XL (Large & Specialty)" (dark blue, smallest segment) |
|||
The segment "AXA XL (Large & Specialty)" has a superscript "1" next to "AXA XL". |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=22|p=11}} |
|||
====== P&C GWP ====== |
|||
* P&C [[Definition:Gross written premiums|GWP]] increased +9% to EUR 5.9bn. |
|||
{{chunk|doc=snjra2xp9r|c=23|p=11}} |
|||
====== P&C | Strong margins, confidence in sustaining growth ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
A table-like diagram with two main columns: "2025" and "Beyond 2025". Rows: |
|||
- Row 1: "Retail and SME & Mid-market" — "Growing volumes while expanding margins" under 2025; "Investing to improve customer retention & expanding distribution footprint" under Beyond 2025. |
|||
- Row 2: "AXA XL (Large & Specialty)" — "Profitable growth with stable margins" under 2025; "Capitalizing on attractive growth opportunities and continued cycle management" under Beyond 2025. |
|||
Below the table, a plus icon is centered, followed by three rounded rectangular boxes: |
|||
- "Continued progress on efficiency" |
|||
- "Higher investment income" |
|||
- "Data & AI to further enhance customer experience & technical excellence" |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=24|p=11}} |
|||
====== P&C | Strong margins, confidence in sustaining growth ====== |
|||
{{fn note|1=1|2=Includes AXA XL Re premiums of €2.6bn.}} |
|||
{{fn note|1=2|2=Change FY25 vs. FY24 at constant FX.}} |
|||
=== L&H| Good momentum, well positioned to capture growth opportunities === |
|||
{{chunk|doc=snjra2xp9r|c=25|p=12}} |
|||
====== L&H| Good momentum, well positioned to capture growth opportunities ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
A donut chart labeled "€57bn [[Definition:Gross written premiums|GWP]]" in the center. The chart is divided into two segments: a dark blue segment labeled "Short-term" and a light blue segment labeled "Long-term". The dark blue segment occupies approximately one-third of the chart, while the light blue segment occupies the remaining two-thirds. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=26|p=12}} |
|||
====== L&H| Good momentum, well positioned to capture growth opportunities ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
A two-column table with headers "2025" and "Beyond 2025". Under "2025", two rows: "Long-term business" with text "Accelerating net flows in Savings at attractive margins", and "Short-term business" with text "Growing technical results while absorbing Mexico VAT impact". Under "Beyond 2025", two rows: "Capturing savings & retirement opportunity, sourcing best asset management products for our customers", and "Capitalizing on demand for health & protection while further improving our margins". Below the table, three rounded rectangular boxes: "Focus on cost reduction", "Increasing penetration of Protection riders in Savings offerings", and "Leveraging AI to reduce claims leakage & improve customer outcomes in Health". A blue circle with a white plus sign is centered below the table and above the three boxes. At the bottom left, text reads "[[Definition:Underlying earnings|Underlying earnings]] +7%{{fn ref|1}} to €3.5bn". At the bottom right, text reads "[[Definition:Full year 2025|Full Year 2025]] Earnings" next to an AXA logo. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=27|p=12}} |
|||
====== Group CFO and FY25 Financial Performance ====== |
|||
* GIE_AXA_Internal Alban de Mailly Nesle is the Group CFO for [[Definition:Full year 2025|FY25]] Financial Performance. |
|||
{{chunk|doc=snjra2xp9r|c=28|p=12}} |
|||
====== L&H| Good momentum, well positioned to capture growth opportunities ====== |
|||
{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}} |
|||
== 3 == |
|||
=== FY25 Financial Performance === |
|||
{{chunk|doc=snjra2xp9r|c=29|p=13}} |
|||
====== Group CFO commentary ====== |
|||
* Alban de Mailly Nesle is the Group CFO. |
|||
=== P&C| Continued disciplined growth === |
|||
=== P&C | Continued disciplined growth === |
=== P&C | Continued disciplined growth === |
||
=== GWP & Other Revenues === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=30|p=14}} |
|||
|+ P&C GWP & other revenues by segment, FY24 vs FY25 <sup>p. 14</sup> |
|||
====== GWP & Other Revenues ====== |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | Change |
|||
A bar chart and table showing [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]] for [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]], broken down by segment, with change metrics. |
|||
! class="col-s" style="text-align:right" | o/w pricing |
|||
! class="col-s" style="text-align:right" | o/w volume |
|||
|- |
|||
| style="text-align:left" | Commercial lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 35.8 |
|||
| style="text-align:right" | +4% |
|||
| style="text-align:right" | +2% |
|||
| style="text-align:right" | +2% |
|||
|- |
|||
| style="text-align:left" | AXA XL Reinsurance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2.6 |
|||
| style="text-align:right" | +8% |
|||
| style="text-align:right" | +0.3% |
|||
| style="text-align:right" | +7% |
|||
|- |
|||
| style="text-align:left" | Retail lines |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 19.7 |
|||
| style="text-align:right" | +7% |
|||
| style="text-align:right" | +5% |
|||
| style="text-align:right" | +2% |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 56.5 |
|||
| style="text-align:right; font-weight:bold" | 58.0 |
|||
| style="text-align:right; font-weight:bold" | +5% |
|||
| style="text-align:right; font-weight:bold" | — |
|||
| style="text-align:right; font-weight:bold" | — |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=31|p=14}} |
|||
====== GWP & Other Revenues by segment ====== |
|||
* Total [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]: EUR 58.0bn in [[Definition:Full year 2025|FY25]] (+5% overall) |
|||
** Commercial lines: EUR 35.8bn |
|||
** AXA XL Reinsurance: EUR 2.6bn |
|||
** Retail lines: EUR 19.7bn |
|||
* Commercial lines GWP & Other Revenues change: +4% (o/w pricing +2%, o/w volume +2%) |
|||
* AXA XL Reinsurance GWP & Other Revenues change: +8% (o/w pricing +0.3%, o/w volume +7%) |
|||
* Retail lines GWP & Other Revenues change: +7% (o/w pricing +5%, o/w volume +2%) |
|||
* Continued pricing momentum and volume growth in Mid-market and SME |
* Continued pricing momentum and volume growth in Mid-market and SME |
||
* |
* Growth in lines of business with attractive margins, maintaining focus on retention at AXA XL Insurance |
||
* Growth supported by alternative capital |
* Growth supported by alternative capital |
||
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) |
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) |
||
{{chunk|doc=snjra2xp9r|c=32|p=14}} |
|||
====== GWP & Other Revenues ====== |
|||
{{fn note|1=1|2=Price effect.}} |
|||
{{fn note|1=2|2=Includes exposure adjustments and mix & other effects.}} |
|||
=== P&C| Delivering further margin expansion while enhancing reserve prudence === |
|||
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
=== P&C | Delivering further margin expansion while enhancing reserve prudence === |
||
==== Combined ratio ==== |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=33|p=15}} |
|||
|+ Combined ratio bridge, FY24 vs FY25 <sup>p. 15</sup> |
|||
====== Combined ratio ====== |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
|- |
|||
Stacked bar chart comparing the Combined ratio for [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat) |
|||
- FY24 Total: 91.0% |
|||
| style="text-align:right" | 67.4% |
|||
- FY25 Total: 90.6% |
|||
| style="text-align:right" | 67.0% |
|||
The bars are composed of the following components: |
|||
|- |
|||
- Undiscounted CY loss ratio (ex Nat Cat): 67.4% in FY24; 67.0% in FY25. |
|||
| style="text-align:left" | Expense ratio |
|||
- Expense ratio: 25.0% in FY24; 24.8% in FY25. |
|||
| style="text-align:right" | 25.0% |
|||
- Nat Cat: 3.8% in FY24; 3.4% in FY25. |
|||
| style="text-align:right" | 24.8% |
|||
- Prior year reserve development: -1.6% in FY24; -1.1% in FY25. |
|||
|- |
|||
- Discount: -3.6% in FY24; -3.5% in FY25. |
|||
| style="text-align:left" | Nat Cat |
|||
| style="text-align:right" | 3.8% |
|||
| style="text-align:right" | 3.4% |
|||
|- |
|||
| style="text-align:left" | Prior year reserve development |
|||
| style="text-align:right" | -1.6% |
|||
| style="text-align:right" | -1.1% |
|||
|- |
|||
| style="text-align:left" | Discount |
|||
| style="text-align:right" | -3.6% |
|||
| style="text-align:right" | -3.5% |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total combined ratio |
|||
| style="text-align:right; font-weight:bold" | 91.0% |
|||
| style="text-align:right; font-weight:bold" | 90.6% |
|||
|} |
|||
</div> |
</div> |
||
* Undiscounted CY loss ratio (ex Nat Cat) improved from: |
|||
{{chunk|doc=snjra2xp9r|c=34|p=15}} |
|||
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment |
|||
====== Undiscounted current year loss ratio ====== |
|||
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management |
|||
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology |
|||
* Undiscounted current year loss ratio (excluding Nat Cat) improved due to margin expansion in Commercial lines SME & mid-market business and Personal lines, reflecting a favorable pricing environment. |
|||
* Nat Cat charges below normalized load |
|||
* Stable AXA XL Insurance margins at attractive levels reflected disciplined cycle management. |
|||
* Prior year reserve development shows lower reliance |
|||
* Improvement in expense ratio reflected the impact of efficiency measures, while continuing investment in growth initiatives and technology. |
|||
* Reserve prudence enhanced by taking advantage of a good year |
|||
* Nat Cat charges were below the normalized load. |
|||
* Lower reliance on prior year reserve development. |
|||
* Enhanced reserve prudence. |
|||
=== P&C| Earnings growth from higher underwriting and financial result === |
|||
=== P&C | Earnings growth from higher underwriting and financial result === |
=== P&C | Earnings growth from higher underwriting and financial result === |
||
{{chunk|doc=snjra2xp9r|c=35|p=16}} |
|||
<div style="overflow-x:auto"> |
|||
====== P&C earnings growth ====== |
|||
{| class="wikitable fintable" |
|||
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 16</sup> |
|||
* All figures are in EUR million. |
|||
! class="col-s" style="text-align:right" | Underlying earnings |
|||
{{chunk|doc=snjra2xp9r|c=36|p=16}} |
|||
|- |
|||
====== P&C | Earnings growth from higher underwriting and financial result ====== |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | 5,510 |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Volume growth |
|||
The image shows a bridge chart for P&C [[Definition:Underlying earnings|Underlying Earnings]] from [[Definition:Full year 2024|FY24]] to [[Definition:Full year 2025|FY25]]. |
|||
| style="text-align:right" | +292 |
|||
- FY24: 5,510 (light blue bar) |
|||
|- |
|||
- Volume growth: +292 |
|||
| style="text-align:left" | Margin improvement |
|||
- Margin improvement: +189 |
|||
| style="text-align:right" | +189 |
|||
- Underwriting result{{fn ref|1}}: (bracket grouping Volume growth and Margin improvement) |
|||
|- |
|||
- Investment income: +435 |
|||
- Insurance finance expenses: -235 |
|||
| style="text-align:right" | +435 |
|||
- Financial result: (bracket grouping Investment income and Insurance finance expenses) |
|||
|- |
|||
- Tax: -169 |
|||
| style="text-align:left" | Insurance finance expenses |
|||
- Affiliates, [[Definition:Foreign exchange|FX]] & other: -150 |
|||
| style="text-align:right" | -235 |
|||
- FY25: 5,872 (dark blue bar) |
|||
|- |
|||
- Total change from FY24 to FY25: +9% (indicated by an arrow above the bridge) |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | -169 |
|||
|- |
|||
| style="text-align:left" | Affiliates, FX & other |
|||
| style="text-align:right" | -150 |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 5,872 |
|||
|} |
|||
</div> |
</div> |
||
* Underlying earnings grew +9% at constant FX to EUR 5,872m. |
|||
{{chunk|doc=snjra2xp9r|c=37|p=16}} |
|||
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence. |
|||
====== P&C earnings drivers ====== |
|||
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets. |
|||
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance. |
|||
* Better underwriting result from strong volume growth and improved all-year combined ratio, while enhancing reserve prudence |
|||
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR. |
|||
* Investment income increased due to higher volumes and better reinvestment yields on fixed income assets |
|||
* Higher unwind of discount of claims reserves, in line with guidance |
|||
* Unfavorable forex impact, notably due to USD depreciation vs. EUR |
|||
{{chunk|doc=snjra2xp9r|c=38|p=16}} |
|||
====== P&C | Earnings growth from higher underwriting and financial result ====== |
|||
{{fn note|1=1|2=Underwriting result includes expenses.}} |
|||
=== Life & Health | Strong growth in premiums, positive net flows === |
=== Life & Health | Strong growth in premiums, positive net flows === |
||
{{chunk|doc=snjra2xp9r|c=39|p=17}} |
|||
<div style="overflow-x:auto"> |
|||
====== Life & Health premiums and net flows ====== |
|||
{| class="wikitable fintable" |
|||
|+ GWP and other revenues by line, FY24 vs FY25 <sup>p. 17</sup> |
|||
* Life & Health premiums and net flows are presented in EUR billion. |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
{{chunk|doc=snjra2xp9r|c=40|p=17}} |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
====== Life & Health | Strong growth in premiums, positive net flows ====== |
|||
! class="col-s" style="text-align:right" | LFL Change |
|||
|- |
|||
<div class="ed-chart-desc"> |
|||
| style="text-align:left" | Life GWP |
|||
[Chart/image description:] |
|||
| style="text-align:right" | 34.5 |
|||
Life [[Definition:Gross written premiums & other revenues|GWP & Other Revenues]] bar chart: [[Definition:Full year 2024|FY24]] total 34.5, [[Definition:Full year 2025|FY25]] total 37.5 (+9%). FY24 breakdown: Protection 17.3 (+11%), Unit-linked 9.3 (+13%), Capital light G/A 9.0 (+7%), Traditional G/A 1.9 (-7%). FY25 breakdown: Protection 17.3, Unit-linked 9.3, Capital light G/A 9.0, Traditional G/A 1.9. |
|||
| style="text-align:right" | 37.5 |
|||
Health GWP & Other Revenues bar chart: FY24 total 17.5, FY25 total 19.0 (+5%). FY24 breakdown: Individual 10.5 (+6%), Group 8.5 (+4%). FY25 breakdown: Individual 10.5, Group 8.5. |
|||
| style="text-align:right" | +9% |
|||
Net flows bar chart: Protection +4.9, Health +2.7, Unit-Linked +1.5, Capital light G/A +1.2, Traditional G/A -5.0. Total net flows: €+5.4bn vs. €+1.5bn in FY24. |
|||
|- |
|||
Footnote below charts: o/w FY25 Employee Benefits¹ Euro 12.9 billion (+4% vs. FY24) |
|||
| style="text-align:left" | Protection |
|||
Footnote 1: Including both short-term and long-term Employee Benefits [[Definition:Gross written premiums|GWP]] and [[Definition:Other revenue|other revenues]]. |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 17.3 |
|||
| style="text-align:right" | +11% |
|||
|- |
|||
| style="text-align:left" | Unit-linked |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 9.3 |
|||
| style="text-align:right" | +13% |
|||
|- |
|||
| style="text-align:left" | Capital light G/A |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 9.0 |
|||
| style="text-align:right" | +7% |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.9 |
|||
| style="text-align:right" | -7% |
|||
|- |
|||
| style="text-align:left" | Health GWP |
|||
| style="text-align:right" | 17.5 |
|||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | +5% |
|||
|- |
|||
| style="text-align:left" | Individual |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 10.5 |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
| style="text-align:left" | Group |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 8.5 |
|||
| style="text-align:right" | +4% |
|||
|- |
|||
| style="text-align:left" | Employee Benefits GWP |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 12.9 |
|||
| style="text-align:right" | +4% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=41|p=17}} |
|||
<div style="overflow-x:auto"> |
|||
====== Life & Health | Strong growth in premiums, positive net flows ====== |
|||
{| class="wikitable fintable" |
|||
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup> |
|||
{{fn note|1=1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}} |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting == |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=42|p=18}} |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
====== Life & Health Gross Written Premiums ====== |
|||
| style="text-align:right; font-weight:bold" | 1.5 |
|||
| style="text-align:right; font-weight:bold" | 5.4 |
|||
* [[Definition:Gross written premiums|Gross Written Premiums]] (GWP) for Life & Health were EUR 3.8bn. |
|||
|- |
|||
| style="text-align:left" | Protection |
|||
{{chunk|doc=snjra2xp9r|c=43|p=18}} |
|||
| style="text-align:right" | — |
|||
====== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
| style="text-align:right" | 4.9 |
|||
|- |
|||
<div class="ed-chart-desc"> |
|||
| style="text-align:left" | Health |
|||
[Chart/image description:] |
|||
| style="text-align:right" | — |
|||
Bar chart showing PVEP (Present Value of Expected Premiums) comparison between [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
| style="text-align:right" | 2.7 |
|||
- Total FY24: 50.9 |
|||
|- |
|||
- Total FY25: 49.4 (-2% change) |
|||
| style="text-align:left" | Unit-Linked |
|||
Breakdown of PVEP: |
|||
| style="text-align:right" | — |
|||
- Protection & Health: FY25 is 31.4 (-4% change) |
|||
| style="text-align:right" | 1.5 |
|||
- Unit-Linked: FY25 is 8.5 (+18% change) |
|||
|- |
|||
- Capital-light G/A: FY25 is 7.8 (-10% change) |
|||
- Traditional G/A: FY25 is 1.7 (-10% change) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.2 |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | -5.0 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=44|p=18}} |
|||
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting === |
|||
====== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
<div |
<div class="ed-chart-desc"> |
||
[Chart/image description:] |
|||
{| class="wikitable fintable" |
|||
Bar chart showing NB CSM (pre-tax) comparison between [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup> |
|||
- FY24: 2.2 |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
- FY25: 2.2 (+3% change) |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | LFL Change |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total PVEP |
|||
| style="text-align:right; font-weight:bold" | 50.9 |
|||
| style="text-align:right; font-weight:bold" | 49.4 |
|||
| style="text-align:right; font-weight:bold" | -2% |
|||
|- |
|||
| style="text-align:left" | Protection & Health |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 31.4 |
|||
| style="text-align:right" | -4% |
|||
|- |
|||
| style="text-align:left" | Unit-Linked |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 8.5 |
|||
| style="text-align:right" | +18% |
|||
|- |
|||
| style="text-align:left" | Capital-light G/A |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7.8 |
|||
| style="text-align:right" | -10% |
|||
|- |
|||
| style="text-align:left" | Traditional G/A |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.7 |
|||
| style="text-align:right" | -10% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=45|p=18}} |
|||
<div style="overflow-x:auto"> |
|||
====== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ====== |
|||
{| class="wikitable fintable" |
|||
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup> |
|||
<div class="ed-chart-desc"> |
|||
! style="text-align:left" | EUR billion |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
Bar chart showing NBV (post-tax) comparison between [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- FY24: 2.3 |
|||
! class="col-s" style="text-align:right" | LFL Change |
|||
- FY25: 2.2 (stable) |
|||
|- |
|||
NBV margin: |
|||
| style="text-align:left" | NB CSM (pre-tax) |
|||
- FY24: 4.4% |
|||
| style="text-align:right" | 2.2 |
|||
- FY25: 4.5% |
|||
| style="text-align:right" | 2.2 |
|||
| style="text-align:right" | +3% |
|||
|- |
|||
| style="text-align:left" | NBV (post-tax) |
|||
| style="text-align:right" | 2.3 |
|||
| style="text-align:right" | 2.2 |
|||
| style="text-align:right" | stable |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=46|p=18}} |
|||
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>. |
|||
====== PVEP and NB CSM ====== |
|||
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>. |
|||
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>. |
|||
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes. |
|||
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup> |
|||
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits. |
|||
{{chunk|doc=snjra2xp9r|c=47|p=18}} |
|||
====== NBV ====== |
|||
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France. |
|||
=== Life & Health | Growth in new business driving Normalized CSM growth === |
=== Life & Health | Growth in new business driving Normalized CSM growth === |
||
==== Contractual Service Margin rollforward ==== |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=48|p=19}} |
|||
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup> |
|||
====== Contractual Service Margin rollforward ====== |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Value |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | FY24 |
|||
Waterfall bar chart showing Contractual Service Margin rollforward from [[Definition:Full year 2024|FY24]] to [[Definition:Full year 2025|FY25]]. FY24 bar: 33.6. New business CSM: +2.2. Underlying return on in-force: +1.3. CSM release: -3.0. A dashed box groups these three bars labeled "Normalized CSM growth +2%". Economic variance: +0.6. Operating variance: -0.3. Affiliates, [[Definition:Foreign exchange|FX]] & other: -1.4. FY25 bar: 33.0. Below the chart: o/w Life FY24: 25.8, FY25: 25.4; o/w Health FY24: 7.7, FY25: 7.6. |
|||
| style="text-align:right" | 33.6 |
|||
- **Normalized CSM up by +2%,** with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates |
|||
|- |
|||
- **Economic variance** reflecting government spreads tightening and positive equity market returns |
|||
| style="text-align:left" | New business CSM |
|||
- **Operating variance** driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland |
|||
| style="text-align:right" | +2.2 |
|||
- **FX** impact mainly from JPY and HKD depreciation |
|||
|- |
|||
| style="text-align:left" | Underlying return on in-force |
|||
| style="text-align:right" | +1.3 |
|||
|- |
|||
| style="text-align:left" | CSM release |
|||
| style="text-align:right" | -3.0 |
|||
|- |
|||
| style="text-align:left" | Economic variance |
|||
| style="text-align:right" | +0.6 |
|||
|- |
|||
| style="text-align:left" | Operating variance |
|||
| style="text-align:right" | -0.3 |
|||
|- |
|||
| style="text-align:left" | Affiliates, FX & other |
|||
| style="text-align:right" | -1.4 |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 33.0 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=49|p=19}} |
|||
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup> |
|||
====== Contractual Service Margin rollforward ====== |
|||
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup> |
|||
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup> |
|||
<div class="ed-chart-desc"> |
|||
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup> |
|||
[Chart/image description:] |
|||
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup> |
|||
No additional chart content visible beyond what is described in P019_B04. |
|||
</div> |
|||
=== Life & Health | Strong momentum in both short-term and long-term business === |
=== Life & Health | Strong momentum in both short-term and long-term business === |
||
{{chunk|doc=snjra2xp9r|c=50|p=20}} |
|||
<div style="overflow-x:auto"> |
|||
====== Financial metrics currency ====== |
|||
{| class="wikitable fintable" |
|||
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 20</sup> |
|||
* All financial figures are presented in EUR million. |
|||
! style="text-align:left" | EUR million |
|||
! class="col-s" style="text-align:right" | Underlying earnings |
|||
{{chunk|doc=snjra2xp9r|c=51|p=20}} |
|||
|- |
|||
====== Life & Health | Strong momentum in both short-term and long-term business ====== |
|||
| style="text-align:left" | FY24 start |
|||
| style="text-align:right" | 3,323 |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Short-term technical margin |
|||
Waterfall chart showing the bridge of [[Definition:Underlying earnings|Underlying Earnings]] from [[Definition:Full year 2024|FY24]] to [[Definition:Full year 2025|FY25]]. |
|||
| style="text-align:right" | +60 |
|||
- FY24 Total: 3,323 |
|||
|- |
|||
- Short-term technical margin: 415 |
|||
| style="text-align:left" | Long-term result incl. CSM release |
|||
- Long-term result incl. CSM release: 2,680 |
|||
| style="text-align:right" | +156 |
|||
- Financial result: 975 |
|||
|- |
|||
- Tax & others: -748 |
|||
| style="text-align:left" | Financial result |
|||
- Bridge steps: |
|||
| style="text-align:right" | -11 |
|||
- Short-term technical margin: +60 |
|||
|- |
|||
- Long-term result incl. CSM release: +156 |
|||
| style="text-align:left" | Tax, FX and others |
|||
- Financial result: -11 |
|||
| style="text-align:right" | -27 |
|||
- Tax, [[Definition:Foreign exchange|FX]] and others: -27 |
|||
|- |
|||
- FY25 Total: 3,501 (+7% change) |
|||
| style="text-align:left" | FY25 end |
|||
- Short-term technical margin: 479 |
|||
| style="text-align:right" | 3,501 |
|||
- Long-term result incl. CSM release: 2,804 |
|||
|} |
|||
- Financial result: 946 |
|||
- Tax & others: -728 |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=52|p=20}} |
|||
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup> |
|||
====== Life & Health technical margin ====== |
|||
* ''Long-term result'' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup> |
|||
* Life technical margin: EUR 2.7bn in [[Definition:Full year 2025|FY25]] (+4% vs. [[Definition:Full year 2024|FY24]]) |
|||
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup> |
|||
* |
* Health technical margin: EUR 0.8bn in FY25 (+17% vs. FY24) |
||
* All figures are in billions. |
|||
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup> |
|||
* Change at constant [[Definition:Foreign exchange|FX]]. |
|||
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup> |
|||
* |
* Strong short-term technical margin reflects underwriting and claims initiatives. |
||
* Initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn). |
|||
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup> |
|||
* Higher long-term results from an 8% increase in CSM release. |
|||
* CSM release increase reflects growth in reserve base, including from favorable equity market performance, and better margins. |
|||
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM === |
||
{{chunk|doc=snjra2xp9r|c=53|p=21}} |
|||
====== Net income by business segment ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t2" class="wikitable fintable" |
||
|- |
|||
|+ Earnings and net income breakdown FY24 vs FY25 <sup>p. 21</sup> |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-m" style="text-align:right" | FY24 |
||
! class="col- |
! class="col-m" style="text-align:right" | FY25 |
||
! class="col- |
! class="col-m" style="text-align:right" | Change |
||
|- |
|- |
||
| style="text-align:left" | Property & Casualty |
| style="text-align:left" | Property & Casualty |
||
| style="text-align:right" | 5.5 |
| style="text-align:right" | 5.5 |
||
| style="text-align:right" | 5.9 |
| style="text-align:right" | 5.9 |
||
| style="text-align:right" | +9% |
| style="text-align:right" | +9% |
||
|- |
|- |
||
| style="text-align:left" | Life & Health |
| style="text-align:left" | Life & Health |
||
| style="text-align:right" | 3.3 |
| style="text-align:right" | 3.3 |
||
| style="text-align:right" | 3.5 |
| style="text-align:right" | 3.5 |
||
| Line 594: | Line 597: | ||
| style="text-align:right" | -57% |
| style="text-align:right" | -57% |
||
|- |
|- |
||
| style="text-align:left" | Holdings & other |
| style="text-align:left" | Holdings & other |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | -1.2 |
| style="text-align:right" | -1.2 |
||
| style="text-align:right" | - |
| style="text-align:right" | - |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <strong>Underlying earnings</strong> |
||
| style="text-align:right" | 8.1 |
| style="text-align:right" | <strong>8.1</strong> |
||
| style="text-align:right" | 8.4 |
| style="text-align:right" | <strong>8.4</strong> |
||
| style="text-align:right" | +6% |
| style="text-align:right" | <strong>+6%</strong> |
||
|- |
|- |
||
| style="text-align:left" | Non-financial flows |
| style="text-align:left" | Non-financial flows |
||
| style="text-align:right" | -0.5 |
| style="text-align:right" | -0.5 |
||
| style="text-align:right" | +2.1 |
| style="text-align:right" | +2.1 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left |
| style="text-align:left" | <em>o/w capital gains from AXA IM disposal</em> |
||
| style="text-align:right" | - |
| style="text-align:right" | - |
||
| style="text-align:right" | +2.2 |
| style="text-align:right" | +2.2 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Financial flows (incl. RCG) |
| style="text-align:left" | Financial flows (incl. RCG) |
||
| style="text-align:right" | +0.3 |
| style="text-align:right" | +0.3 |
||
| style="text-align:right" | -0.7 |
| style="text-align:right" | -0.7 |
||
| style="text-align:right" | |
| style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <strong>Net income</strong> |
||
| style="text-align:right" | 7.9 |
| style="text-align:right" | <strong>7.9</strong> |
||
| style="text-align:right" | 9.8 |
| style="text-align:right" | <strong>9.8</strong> |
||
| style="text-align:right" | +26% |
| style="text-align:right" | <strong>+26%</strong> |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=54|p=21}} |
|||
<div style="overflow-x:auto"> |
|||
====== Net income drivers ====== |
|||
{| class="wikitable fintable" |
|||
|+ Underlying earnings per share bridge, FY24 to FY25 <sup>p. 21</sup> |
|||
* Insurance businesses showed strong performance. |
|||
! style="text-align:left" | EUR |
|||
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]]. |
|||
! class="col-s" style="text-align:right" | Underlying earnings per share |
|||
* Net income was higher, mainly reflecting higher [[Definition:Underlying earnings|underlying earnings]] and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]]. |
|||
|- |
|||
* Financial flows were lower, reflecting an unfavorable forex impact. |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | 3.59 |
|||
=== Underlying earnings per share In Euro === |
|||
|- |
|||
| style="text-align:left" | Earnings growth |
|||
=== Underlying earnings per share === |
|||
| style="text-align:right" | +6% |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=55|p=21}} |
|||
| style="text-align:left" | Capital management |
|||
====== Currency basis ====== |
|||
| style="text-align:right" | +3% |
|||
|- |
|||
* All figures are presented in Euro. |
|||
| style="text-align:left" | Forex |
|||
| style="text-align:right" | -2% |
|||
{{chunk|doc=snjra2xp9r|c=56|p=21}} |
|||
|- |
|||
====== Underlying earnings per share ====== |
|||
| style="text-align:left" | Temporary earnings dilution from AXA IM sale |
|||
| style="text-align:right" | -1% |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | FY25 |
|||
Bar chart showing [[Definition:Underlying earnings per share|Underlying earnings per share]] in Euro. [[Definition:Full year 2024|FY24]] bar (light blue): 3.59. [[Definition:Full year 2025|FY25]] bar (dark navy): 3.86. A bracket above indicates +8% overall change between FY24 and FY25. |
|||
| style="text-align:right" | 3.86 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=57|p=21}} |
|||
* ''Underlying earnings'' drivers: |
|||
====== Underlying earnings per share growth drivers ====== |
|||
** Strong performance from insurance businesses <sup>p. 21</sup> |
|||
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup> |
|||
* ''Net income'' drivers: |
|||
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup> |
|||
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup> |
|||
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup> |
|||
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup> |
|||
* [[Definition:Underlying earnings per share|Underlying earnings per share]] growth was +6% from earnings growth. |
|||
=== Shareholders' equity === |
|||
* Underlying earnings per share growth was +3% from [[Definition:Capital management|capital management]]. |
|||
* Underlying earnings per share growth was -2% from forex. |
|||
* Underlying earnings per share growth included -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to the timing of the anti-dilutive [[Definition:Share buyback|share buyback]] related to the [[Definition:AXA Investment Managers|AXA IM]] sale. |
|||
{{chunk|doc=snjra2xp9r|c=58|p=21}} |
|||
* (stacked bar) ''Shareholders' equity'' Group share: |
|||
====== Underlying earnings per share ====== |
|||
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup> |
|||
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup> |
|||
<div class="ed-chart-desc"> |
|||
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup> |
|||
[Chart/image description:] |
|||
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup> |
|||
Dashed-border callout box reiterating the note about -1% from temporary [[Definition:Earnings dilution|earnings dilution]] from [[Definition:AXA Investment Managers|AXA IM]] sale due to the timing of anti-dilutive [[Definition:Share buyback|share buyback]]. |
|||
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup> |
|||
</div> |
|||
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup> |
|||
=== Shareholders’ Equity === |
|||
{{chunk|doc=snjra2xp9r|c=59|p=22}} |
|||
====== Shareholders' Equity ====== |
|||
* Shareholders' Equity in Euro billion. |
|||
{{chunk|doc=snjra2xp9r|c=60|p=22}} |
|||
====== Shareholders’ Equity ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
The image shows a bar chart and key metrics for Shareholders' equity{{fn ref|1}}. |
|||
The bar chart has three columns representing [[Definition:Full year 2024|FY24]], HY25, and [[Definition:Full year 2025|FY25]]. |
|||
- FY24: Total Shareholders' equity is 49.9. This is composed of SHE (excl. OCI) of 58.0 and Net OCI of -8.1. |
|||
- HY25: Total Shareholders' equity is 45.5. This is composed of SHE (excl. OCI) of 52.7 and Net OCI of -7.2. |
|||
- FY25: Total Shareholders' equity is 47.2. This is composed of SHE (excl. OCI) of 54.0 and Net OCI of -6.8. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=61|p=22}} |
|||
====== Key financial metrics ====== |
|||
* SHE (excl. OCI & undated subordinated debt): EUR 53.2bn in [[Definition:Full year 2024|FY24]]; EUR 47.0bn in HY25; EUR 49.4bn in [[Definition:Full year 2025|FY25]] |
|||
* Debt gearing: 20.6% in FY24; 23.4% in HY25; 22.3% in FY25 |
|||
* Underlying ROE: 15.2% in FY24; 17.5% in HY25; 16.0% in FY25 |
|||
{{chunk|doc=snjra2xp9r|c=62|p=22}} |
|||
====== Shareholders' equity by FY24 to FY25 and HY25 to FY25 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t3" class="wikitable fintable" |
||
|- |
|||
|+ Shareholders' equity roll-forward <sup>p. 22</sup> |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | FY24 to FY25 |
! class="col-s" style="text-align:right" | FY24 to FY25 |
||
! class="col-s" style="text-align:right" | HY25 to FY25 |
! class="col-s" style="text-align:right" | HY25 to FY25 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Opening Shareholders' equity |
||
| style="text-align:right" | 49.9 |
| style="text-align:right" | 49.9 |
||
| style="text-align:right" | 45.5 |
| style="text-align:right" | 45.5 |
||
| Line 714: | Line 742: | ||
| style="text-align:right" | 0.3 |
| style="text-align:right" | 0.3 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Closing Shareholders' equity |
||
| style="text-align:right" | 47.2 |
| style="text-align:right" | 47.2 |
||
| style="text-align:right" | 47.2 |
| style="text-align:right" | 47.2 |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=1. Shareholders' equity Group share.}} |
|||
=== Higher organic cash remittance and robust cash position at Holding === |
=== Higher organic cash remittance and robust cash position at Holding === |
||
=== Net Cash Remittance === |
|||
* (bar) ''Net cash remittance'' trend: |
|||
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup> |
|||
{{chunk|doc=snjra2xp9r|c=63|p=23}} |
|||
** ''FY25'': EUR 7.5bn total <sup>p. 23</sup> |
|||
====== Net Cash Remittance ====== |
|||
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup> |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Bar chart showing Net Cash Remittance for [[Definition:Full year 2024|FY24]] and [[Definition:Full year 2025|FY25]]. |
|||
- FY24 total is 7.7, consisting of: |
|||
- 7.1 (light blue bar) |
|||
- 0.6 (patterned bar at the top, labeled "Proceeds related to in-force treaties²") |
|||
- FY25 total is 7.5 (dark blue bar) |
|||
- Below the bars, "Remittance ratio¹" is shown: |
|||
- FY24: 82% (grey oval) |
|||
- FY25: 82% (dark blue oval) |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=64|p=23}} |
|||
====== Net Cash Remittance ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t4" class="wikitable fintable" |
||
|+ Holding cash position bridge FY24 to FY25 in Euro billion <sup>p. 23</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>FY24 Cash position</b> |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | <b>4.0</b> |
||
|- |
|- |
||
| style="text-align:left" | Net cash remittance from subsidiaries |
| style="text-align:left" | Net cash remittance from subsidiaries |
||
| Line 754: | Line 796: | ||
| style="text-align:right" | +1.6 |
| style="text-align:right" | +1.6 |
||
|- |
|- |
||
| style="text-align:left" | M&A and other |
| style="text-align:left" | M&A and other |
||
| style="text-align:right" | +3.1 |
| style="text-align:right" | +3.1 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>FY25 Cash position</b> |
||
| style="text-align:right" | 5.6 |
| style="text-align:right" | <b>5.6</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.}} |
|||
{{fn note|1=2|2=2. €0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.}} |
|||
=== Solvency II at 224% === |
=== Solvency II at 224% === |
||
{{chunk|doc=snjra2xp9r|c=65|p=24}} |
|||
<div style="overflow-x:auto"> |
|||
====== Solvency II at 224% ====== |
|||
{| class="wikitable fintable" |
|||
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup> |
|||
<div class="ed-chart-desc"> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | EOF |
|||
Left column: Three stacked bar charts titled "Solvency II at 224%" with unit "In Euro billion". |
|||
! class="col-s" style="text-align:right" | SCR |
|||
Top chart: "Eligible Own Funds (EOF)". [[Definition:Full year 2024|FY24]] bar at 55.9, [[Definition:Full year 2025|FY25]] bar at 56.4. Between them, a waterfall of changes: +0.2, +8.8, -0.4, -2.1, -6.0, -0.1. A note above the -6.0 bar reads: "Foreseeable [[Definition:Dividend|dividends]]: €4.8bn Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: €1.25bn". |
|||
! class="col-s" style="text-align:right" | Solvency II ratio (pts) |
|||
Middle chart: "Solvency II ratio". FY24 value 216%, FY25 value 224%. Between them, a flow of changes: +0pt (Regulatory & model changes), +28pts (Normalized capital generation), -1pt (Operating variance), +4pts (Economic variance & [[Definition:Foreign exchange|FX]]), -24pts (Dividend & annual share buyback), +2pts (Management actions, debt & other). |
|||
|- |
|||
Bottom chart: "Solvency Capital Requirement (SCR)". FY24 bar at 25.9, FY25 bar at 25.2. Between them, a waterfall: 0.0, +0.6, 0.0, -1.2, 0.0, -0.2. |
|||
| style="text-align:left" | FY24 |
|||
| style="text-align:right" | 55.9 |
|||
| style="text-align:right" | 25.9 |
|||
| style="text-align:right" | 216 |
|||
|- |
|||
| style="text-align:left" | Regulatory & model changes |
|||
| style="text-align:right" | +0.2 |
|||
| style="text-align:right" | 0.0 |
|||
| style="text-align:right" | +0 |
|||
|- |
|||
| style="text-align:left" | Normalized capital generation |
|||
| style="text-align:right" | +8.8 |
|||
| style="text-align:right" | +0.6 |
|||
| style="text-align:right" | +28 |
|||
|- |
|||
| style="text-align:left" | Operating variance |
|||
| style="text-align:right" | -0.4 |
|||
| style="text-align:right" | 0.0 |
|||
| style="text-align:right" | -1 |
|||
|- |
|||
| style="text-align:left" | Economic variance & FX |
|||
| style="text-align:right" | -2.1 |
|||
| style="text-align:right" | -1.2 |
|||
| style="text-align:right" | +4 |
|||
|- |
|||
| style="text-align:left" | Dividend & annual share buyback |
|||
| style="text-align:right" | -6.0 |
|||
| style="text-align:right" | 0.0 |
|||
| style="text-align:right" | -24 |
|||
|- |
|||
| style="text-align:left" | Management actions, debt & other |
|||
| style="text-align:right" | -0.1 |
|||
| style="text-align:right" | -0.2 |
|||
| style="text-align:right" | +2 |
|||
|- |
|||
| style="text-align:left" | FY25 |
|||
| style="text-align:right" | 56.4 |
|||
| style="text-align:right" | 25.2 |
|||
| style="text-align:right" | 224 |
|||
|} |
|||
</div> |
</div> |
||
=== Key sensitivities === |
|||
* Foreseeable dividends accounted for -EUR 4.8bn. |
|||
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn. |
|||
{{chunk|doc=snjra2xp9r|c=66|p=24}} |
|||
<div style="overflow-x:auto"> |
|||
====== Key sensitivities ====== |
|||
{| class="wikitable fintable" |
|||
|+ Key sensitivities of Solvency II ratio as of December 31, 2025 (base 224%) <sup>p. 24</sup> |
|||
<div class="ed-chart-desc"> |
|||
! style="text-align:left" | Sensitivity |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | Impact (pts) |
|||
Right column: Horizontal bar chart titled "Key sensitivities". Subtitle: "Ratio as of December 31, 2025" with value 224% shown in a dark blue bar. |
|||
|- |
|||
Bars (left to right, light blue): |
|||
| style="text-align:left" | Interest rate +50bps |
|||
- Interest rate +50bps: +2 pts |
|||
| style="text-align:right" | +2 |
|||
- Interest rate -50bps: -1 pt |
|||
|- |
|||
- Corporate spreads +50bps: -1 pt |
|||
| style="text-align:left" | Interest rate -50bps |
|||
- Euro Sovereign spreads +50bps{{fn ref|1}}: -7 pts |
|||
| style="text-align:right" | -1 |
|||
- Credit migration{{fn ref|2}}: -4 pts |
|||
|- |
|||
- Listed Equity (excl. PE & Infra) +25%: -1 pt |
|||
| style="text-align:left" | Corporate spreads +50bps |
|||
- Listed Equity (excl. PE & Infra) -25%: +2 pts |
|||
| style="text-align:right" | -1 |
|||
- PE & Infra +25%: +14 pts |
|||
|- |
|||
- PE & Infra -25%: -19 pts |
|||
| style="text-align:left" | Euro Sovereign spreads +50bps |
|||
- Inflation swap curve +50bps: -5 pts |
|||
| style="text-align:right" | -7 |
|||
|- |
|||
| style="text-align:left" | Credit migration |
|||
| style="text-align:right" | -4 |
|||
|- |
|||
| style="text-align:left" | Listed Equity (excluding PE & Infra) +25% |
|||
| style="text-align:right" | -1 |
|||
|- |
|||
| style="text-align:left" | Listed Equity (excluding PE & Infra) -25% |
|||
| style="text-align:right" | +2 |
|||
|- |
|||
| style="text-align:left" | PE & Infra +25% |
|||
| style="text-align:right" | +14 |
|||
|- |
|||
| style="text-align:left" | PE & Infra -25% |
|||
| style="text-align:right" | -19 |
|||
|- |
|||
| style="text-align:left" | Inflation swap curve +50bps |
|||
| style="text-align:right" | -5 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=67|p=24}} |
|||
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures. |
|||
====== Key sensitivities ====== |
|||
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches). |
|||
{{fn note|1=1|2=Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}} |
|||
{{fn note|1=2|2=Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).}} |
|||
== Solvency II – impact of the end of grandfathering period and Solvency II revision == |
|||
{{chunk|doc=snjra2xp9r|c=68|p=25}} |
|||
=== Solvency II -impact of the end of grandfathering period and Solvency II revision === |
|||
====== Solvency II – impact of the end of grandfathering period and Solvency II revision ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
A visual representation of Solvency II ratio impacts: |
|||
- Ratio as of 31/12/2025: represented by a dark blue bar, showing 224% |
|||
- Impact of the end of grandfathering period on January 1, [[Definition:Year 2026|2026]]: represented by a light blue bar, showing -10pts to 215% |
|||
- Impact of Solvency II revision to come into effect in 1Q27: represented by a light blue bar, showing +17pts |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=69|p=25}} |
|||
====== Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t5" class="wikitable" |
||
|+ Solvency II ratio impacts <sup>p. 25</sup> |
|||
! style="text-align:left" | Event |
|||
! class="col-s" style="text-align:right" | Impact (pts) |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Ratio as of 31/12/2025 |
||
| style="text-align:right" | 224 |
| style="text-align:right" | 224% |
||
| style="text-align:left" | |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026 |
||
| style="text-align:right" | - |
| style="text-align:right" | -10pts to 215% |
||
| style="text-align:left" | ▶ Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
|||
|- |
|- |
||
| style="text-align:left" | Solvency II revision |
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27 |
||
| style="text-align:right" | + |
| style="text-align:right" | +17pts{{fn ref|1}} |
||
| style="text-align:left" | |
|||
|} |
|} |
||
</div> |
</div> |
||
▶ No change expected in organic capital generation<br/> |
|||
▶ Additional capital flexibility |
|||
</td> |
|||
</tr> |
|||
</table> |
|||
{{fn note|1=1|2=1. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}} |
|||
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026. |
|||
* No change is expected in organic capital generation. |
|||
* Provides additional capital flexibility. |
|||
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date. |
|||
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>. |
|||
== Thomas Buberl, Group CEO Conclusion == |
|||
=== Conclusion === |
|||
* ''Section divider'' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=70|p=26}} |
|||
====== Group CEO statement ====== |
|||
* Thomas Buberl is the Group CEO. |
|||
=== Conclusion === |
=== Conclusion === |
||
{{chunk|doc=snjra2xp9r|c=71|p=27}} |
|||
* ''Record results'' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>. |
|||
====== Business performance and outlook ====== |
|||
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>. |
|||
* ''Diversified franchise'' well-positioned to capture future growth opportunities <sup>p. 27</sup>. |
|||
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>. |
|||
* Record results achieved at the top end of the [[Definition:Target range|target range]], while enhancing reserve prudence. |
|||
=== February 26, 2026 Q&A Full Year 2025 earnings === |
|||
* All businesses are in excellent shape, delivering strong growth and profitability. |
|||
* The diversified franchise is well-positioned to capture future growth opportunities. |
|||
* Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth. |
|||
=== February 26, 2026 Q&A Full Year 2025 Earnings === |
|||
=== Q&A === |
|||
=== Full Year 2025 Earnings === |
|||
=== AXA Investor Relations | Keep in touch === |
=== AXA Investor Relations | Keep in touch === |
||
{{chunk|doc=snjra2xp9r|c=72|p=29}} |
|||
* ''Investor Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup> |
|||
====== AXA Investor Relations | Keep in touch ====== |
|||
* ''Follow us'': www.axa.com <sup>p. 29</sup> |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Icon of a person/headset representing "Meet our management" |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=73|p=29}} |
|||
====== AXA Investor Relations | Keep in touch ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Handshake icon next to the "Meet our management" heading. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=74|p=29}} |
|||
====== AXA Investor Relations | Keep in touch ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t6" class="wikitable" |
||
|+ Meet our management event schedule <sup>p. 29</sup> |
|||
! style="text-align:left" | Date |
|||
! class="col-m" style="text-align:right" | Event |
|||
! class="col-m" style="text-align:right" | Location |
|||
|- |
|- |
||
! style="text-align:left" | March |
|||
! style="text-align:right" | Roadshows |
|||
! style="text-align:right" | Europe and US |
|||
|- |
|||
| style="text-align:left" | May 5 |
|||
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2 |
|||
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | June 2-4 |
|||
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference |
|||
| class="col-m" style="text-align:right" | Zurich |
|||
|- |
|||
| style="text-align:left" | July 31 |
|||
| class="col-m" style="text-align:right" | HY26 Earnings Release |
|||
| class="col-m" style="text-align:right" | Paris |
|||
|- |
|||
| style="text-align:left" | September 21 |
|||
| class="col-m" style="text-align:right" | AXA Investor Day |
|||
| class="col-m" style="text-align:right" | London |
|||
|} |
|} |
||
</div> |
</div> |
||
<tr><td>May 5</td><td>1Q25 Activity Indicators</td><td>Paris</td></tr> |
|||
<tr><td>June 2</td><td>BNP Paribas Exane CEO Conference</td><td>Paris</td></tr> |
|||
<tr><td>June 2-4</td><td>Goldman Sachs European Financials Conference</td><td>Zurich</td></tr> |
|||
<tr><td>July 31</td><td>HY26 [[Definition:Earnings release|Earnings Release]]</td><td>Paris</td></tr> |
|||
<tr><td>September 21</td><td>AXA Investor Day</td><td>London</td></tr> |
|||
</table> |
|||
{{chunk|doc=snjra2xp9r|c=75|p=29}} |
|||
== Appendices == |
|||
====== Investor Relations contact information ====== |
|||
* Investor Relations contact number: +33 1 40 75 48 42 |
|||
* Section divider for ''Appendices'' <sup>p. 30</sup> |
|||
* Investor Relations email: investor.relations@axa.com |
|||
=== |
=== Follow us === |
||
{{chunk|doc=snjra2xp9r|c=76|p=29}} |
|||
* ''Debt and Invested Assets'' <sup>p. 31</sup> |
|||
====== Follow us ====== |
|||
* ''Additional P&C disclosures'' <sup>p. 36</sup> |
|||
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup> |
|||
* ''Sustainability'' <sup>p. 44</sup> |
|||
<div class="ed-chart-desc"> |
|||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
|||
[Chart/image description:] |
|||
www.axa.com link next to "Follow us" heading. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=77|p=29}} |
|||
<div style="overflow-x:auto"> |
|||
====== Follow us ====== |
|||
{| class="wikitable fintable" |
|||
|+ Gross financial debt <sup>p. 32</sup> |
|||
<div class="ed-chart-desc"> |
|||
! style="text-align:left" | EUR billion unless otherwise mentioned |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
YouTube icon. |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Jan 1st 2026 |
|||
|- |
|||
| style="text-align:left" | Tier 1 |
|||
| style="text-align:right" | 4.8 |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 3.2 |
|||
|- |
|||
| style="text-align:left" | Tier 2 |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 12.2 |
|||
| style="text-align:right" | 11.3 |
|||
|- |
|||
| style="text-align:left" | Senior debt |
|||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 3.5 |
|||
| style="text-align:right" | 5.8 |
|||
|- |
|||
| style="text-align:left; font-weight:bold" | Total |
|||
| style="text-align:right; font-weight:bold" | 19.2 |
|||
| style="text-align:right; font-weight:bold" | 20.3 |
|||
| style="text-align:right; font-weight:bold" | 20.3 |
|||
|- |
|||
| style="text-align:left" | Debt gearing |
|||
| style="text-align:right" | 20.6% |
|||
| style="text-align:right" | 22.3% |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=78|p=29}} |
|||
<div style="overflow-x:auto"> |
|||
====== Follow us ====== |
|||
{| class="wikitable fintable" |
|||
|+ Contractual maturity breakdown <sup>p. 32</sup> |
|||
* Follow AXA on Twitter: @AXA. |
|||
! style="text-align:left" | EUR billion |
|||
* Follow AXA on LinkedIn: AXA. |
|||
! class="col-s" style="text-align:right" | Tier 1 |
|||
* Follow AXA on Instagram: @AXA. |
|||
! class="col-s" style="text-align:right" | Tier 2 |
|||
* Follow AXA on YouTube: AXA. |
|||
! class="col-s" style="text-align:right" | Senior debt |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=79|p=29}} |
|||
| style="text-align:left" | 2028 |
|||
====== Follow us ====== |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
<div class="ed-chart-desc"> |
|||
| style="text-align:right" | 0.5 |
|||
[Chart/image description:] |
|||
|- |
|||
Instagram icon. |
|||
| style="text-align:left" | 2030 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.9 |
|||
|- |
|||
| style="text-align:left" | 2031-2039 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1.5 |
|||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 10.8 |
|||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 4.6 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Grandfathered debt (contractual) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 1 Undated |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 2 2030 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 2 ≥2040 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | — |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=80|p=29}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Twitter/X icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=81|p=29}} |
|||
====== Follow us ====== |
|||
* Follow AXA on LinkedIn, X, Instagram, and YouTube. |
|||
* Visit AXA's website at axa.com. |
|||
{{chunk|doc=snjra2xp9r|c=82|p=29}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Sustainability/leaf icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=83|p=29}} |
|||
====== Follow us ====== |
|||
* "O" |
|||
{{chunk|doc=snjra2xp9r|c=84|p=29}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Additional social/web icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=85|p=29}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Additional icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=86|p=29}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Additional icon. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=87|p=30}} |
|||
====== Follow us ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
The image is a section divider page with a dark blue background. In the top left corner is the AXA logo, which consists of the word "AXA" in white within a white-outlined square, with a red diagonal slash through the top right corner of the square. The background features large, diagonal, translucent bands of purple and magenta. In the center of the page, the word "Appendices" is written in large, white, sans-serif font with a slight drop shadow. To the left of the word "Appendices" is a solid red diagonal parallelogram. |
|||
</div> |
|||
== Appendices == |
|||
{{chunk|doc=snjra2xp9r|c=88|p=31}} |
|||
====== Additional P&C disclosures ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t7" class="wikitable" |
||
|+ Economic maturity breakdown <sup>p. 32</sup> |
|||
! style="text-align:left" | EUR billion |
|||
! class="col-s" style="text-align:right" | Tier 1 |
|||
! class="col-s" style="text-align:right" | Tier 2 |
|||
! class="col-s" style="text-align:right" | Senior debt |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1. |
||
| style="text-align: |
| style="text-align:left" | Debt and Invested Assets |
||
| style="text-align:right" | |
| style="text-align:right" | p.31 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2. |
||
| style="text-align: |
| style="text-align:left" | Additional P&C disclosures |
||
| style="text-align:right" | |
| style="text-align:right" | p.36 |
||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 3. |
||
| style="text-align: |
| style="text-align:left" | Additional IFRS17 disclosures |
||
| style="text-align:right" | |
| style="text-align:right" | p.41 |
||
| style="text-align:right" | 0.5 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 4. |
||
| style="text-align: |
| style="text-align:left" | Sustainability |
||
| style="text-align:right" | |
| style="text-align:right" | p.44 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | 2030 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | 0.9 |
|||
|- |
|||
| style="text-align:left" | 2031-2039 |
|||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | 6.4 |
|||
| style="text-align:right" | 1.5 |
|||
|- |
|||
| style="text-align:left" | ≥2040 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.5 |
|||
|- |
|||
| style="text-align:left" | Undated |
|||
| style="text-align:right" | 4.0 |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Grandfathered debt (economic) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 1 2026 |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 1 2028 |
|||
| style="text-align:right" | 0.1 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 1 2031-2039 |
|||
| style="text-align:right" | 0.4 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 1 Undated |
|||
| style="text-align:right" | 0.8 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 2 2030 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.7 |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tier 2 ≥2040 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:right" | — |
|||
|} |
|} |
||
</div> |
</div> |
||
=== Gross financial debt and maturity breakdown as of December 31 st , 2025 === |
|||
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005). |
|||
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt. |
|||
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity. |
|||
=== Gross financial debt and maturity breakdown as of December 31st, 2025 === |
|||
=== General account invested assets === |
|||
=== Gross financial debt === |
|||
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>. |
|||
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=89|p=32}} |
|||
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>. |
|||
====== Gross financial debt ====== |
|||
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>. |
|||
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>. |
|||
<div class="ed-chart-desc"> |
|||
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>. |
|||
[Chart/image description:] |
|||
The chart displays "Gross financial debt" with two vertical bar stacks labeled "[[Definition:Full year 2024|FY24]]" and "[[Definition:Full year 2025|FY25]]", and a third labeled "Jan 1st [[Definition:Year 2026|2026]] End of the grandfathering period". Each bar is segmented into three tiers: Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The FY24 bar totals 19.2, with segments 3.5 (Senior), 10.8 (Tier 2), and 4.8 (Tier 1). The FY25 bar totals 20.3, with segments 3.5 (Senior), 12.2 (Tier 2), and 4.6 (Tier 1). The Jan 1st 2026 bar totals 20.3, with segments 5.8 (Senior), 11.3 (Tier 2), and 3.2 (Tier 1). A note in a dashed box points to the Jan 1st 2026 bar, stating "o/w €0.4bn redeemed in Jan 2026". Above the FY24 and FY25 bars, two ovals show "Debt gearing" percentages: 20.6% for FY24 and 22.3% for FY25. A legend at the bottom identifies the colors: dark blue for Tier 1, medium blue for Tier 2, and light blue for Senior debt. |
|||
</div> |
|||
=== Contractual maturity breakdown === |
|||
{{chunk|doc=snjra2xp9r|c=90|p=32}} |
|||
====== Contractual maturity breakdown ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
This bar chart shows debt maturity by year from 2025 to ≥2040 and "Undated", broken down by Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The total for each year is shown above the stacked bars. 2025: 0.5 (all Senior). [[Definition:Year 2026|2026]]: 0.7 (all Tier 2). 2027: 0.9 (all Tier 2). 2028: 1.5 (all Senior). 2029: 0.7 (all Tier 2). 2030: 0.9 (all Tier 2). 2031-2039: 1.5 (all Senior). ≥2040: 0.5 (all Senior). Undated: 0.7 (all Tier 2) and 4.6 (all Tier 1). Below the main chart, a section titled "o/w Grandfathered debt" shows two rows for Tier 1 and Tier 2, with dashed boxes for each year. Tier 1: 1.4 in "Undated". Tier 2: 0.7 in 2029, 0.2 in ≥2040. A legend on the right identifies the colors. |
|||
</div> |
|||
=== Economic maturity breakdown === |
|||
{{chunk|doc=snjra2xp9r|c=91|p=32}} |
|||
====== Economic maturity breakdown ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
This bar chart shows economic maturity by year from 2025 to ≥2040 and "Undated", broken down by Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The total for each year is shown above the stacked bars. 2025: 0.1 (all Tier 2). [[Definition:Year 2026|2026]]: 2.4 (all Tier 2). 2027: 0.1 (all Tier 1) and 0.5 (all Tier 2). 2028: 2.0 (all Tier 2). 2029: 0.7 (all Tier 2). 2030: 0.9 (all Tier 2). 2031-2039: 1.5 (all Senior) and 6.4 (all Tier 2). ≥2040: 0.5 (all Senior). Undated: 0.7 (all Tier 2) and 4.0 (all Tier 1). Below the main chart, a section titled "o/w Grandfathered debt" shows two rows for Tier 1 and Tier 2, with dashed boxes for each year. Tier 1: 0.1 in 2026, 0.1 in 2028, 0.4 in 2031-2039, 0.8 in "Undated". Tier 2: 0.7 in 2029, 0.2 in ≥2040. A legend on the right identifies the colors. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=92|p=32}} |
|||
====== Economic maturity breakdown ====== |
|||
{{fn note|1=1|2=Nominal debt.}} |
|||
{{fn note|1=2|2=In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable January 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.}} |
|||
{{fn note|1=3|2=Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}} |
|||
== General Account Invested Assets == |
|||
{{chunk|doc=snjra2xp9r|c=93|p=33}} |
|||
====== General Account Invested Assets ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
A donut chart showing the breakdown of [[Definition:Full year 2025|FY25]] Total General Account invested assets. |
|||
The center of the donut chart reads: |
|||
Euro |
|||
450 |
|||
billion |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=94|p=33}} |
|||
====== FY25 General Account Invested Assets Composition ====== |
|||
* Duration gap for General Account invested assets was -0.4 years. |
|||
* Total General Account invested assets composition: |
|||
** Fixed income: ~77% |
|||
** Real estate: ~9% |
|||
** Private equity and hedge funds: ~5% |
|||
** Cash: ~4% |
|||
** Infrastructure equity: ~2% |
|||
** Listed equities: ~2% |
|||
** Policy loans: ~0% |
|||
{{chunk|doc=snjra2xp9r|c=95|p=33}} |
|||
====== Invested assets (100%)<br/>In Euro billion ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t8" class="wikitable fintable" |
||
|- |
|||
|+ Invested assets breakdown FY25 <sup>p. 33</sup> |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | % |
! class="col-s" style="text-align:right" | % |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Fixed income |
||
| style="text-align:right" | 345 |
| style="text-align:right" | 345 |
||
| style="text-align:right" | 77% |
| style="text-align:right" | 77% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | o/w Government bonds |
||
| style="text-align:right" | 167 |
| style="text-align:right" | 167 |
||
| style="text-align:right" | 37% |
| style="text-align:right" | 37% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | o/w Corporate bonds and loans |
||
| style="text-align:right" | 121 |
| style="text-align:right" | 121 |
||
| style="text-align:right" | 27% |
| style="text-align:right" | 27% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | o/w Other fixed income {{fn ref|1}} |
||
| style="text-align:right" | 56 |
| style="text-align:right" | 56 |
||
| style="text-align:right" | 13% |
| style="text-align:right" | 13% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Real estate |
||
| style="text-align:right" | 41 |
| style="text-align:right" | 41 |
||
| style="text-align:right" | 9% |
| style="text-align:right" | 9% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Infrastructure equity |
||
| style="text-align:right" | 10 |
| style="text-align:right" | 10 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Listed equities {{fn ref|2}} |
||
| style="text-align:right" | 10 |
| style="text-align:right" | 10 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Private equity and hedge funds {{fn ref|3}} |
||
| style="text-align:right" | 23 |
| style="text-align:right" | 23 |
||
| style="text-align:right" | 5% |
| style="text-align:right" | 5% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Cash |
||
| style="text-align:right" | 19 |
| style="text-align:right" | 19 |
||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Policy loans |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total Insurance Invested Assets {{fn ref|4}} |
||
| style="text-align:right" | 450 |
| style="text-align:right" | 450 |
||
| style="text-align:right" | 100% |
| style="text-align:right" | 100% |
||
| Line 1,190: | Line 1,197: | ||
</div> |
</div> |
||
{{fn note|1=1|2=1. Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}} |
|||
=== Structured and private credit assets === |
|||
{{fn note|1=2|2=2. Includes hedges. Listed equities excluding hedges at Euro 14 billion.}} |
|||
{{fn note|1=3|2=3. Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}} |
|||
{{fn note|1=4|2=4. Please refer to the financial supplement for more details.}} |
|||
=== Structured and Private Credit assets === |
|||
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=96|p=34}} |
|||
====== Structured and Private Credit assets ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t9" class="wikitable fintable" |
||
|- |
|||
|+ Structured and private credit assets breakdown FY25 <sup>p. 34</sup> |
|||
! style="text-align:left" | Invested assets (100%) |
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
! class="col-s" style="text-align:right" | % of total G/A |
! class="col-s" style="text-align:right" | % of total G/A{{fn ref|1}}<br/>portfolio |
||
! |
! style="text-align:left" | Comments |
||
|- |
|- |
||
| style="text-align:left" | Residential Mortgages |
| style="text-align:left" | Residential Mortgages |
||
| style="text-align:right" | 16 |
| style="text-align:right" | 16 |
||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
| style="text-align: |
| style="text-align:left" | - €6bn Dutch mortgages, NHG guaranteed<br/>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
||
|- |
|- |
||
| style="text-align:left" | CLO & ABS |
| style="text-align:left" | CLO & ABS |
||
| style="text-align:right" | 25 |
| style="text-align:right" | 25 |
||
| style="text-align:right" | 6% |
| style="text-align:right" | 6% |
||
| style="text-align: |
| style="text-align:left" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
||
|- |
|- |
||
| style="text-align:left" | Infrastructure debt |
| style="text-align:left" | Infrastructure debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align: |
| style="text-align:left" | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
||
|- |
|- |
||
| style="text-align:left" | CRE debt |
| style="text-align:left" | CRE debt |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align: |
| style="text-align:left" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
||
|- |
|- |
||
| style="text-align:left" | Mid-Market lending |
| style="text-align:left" | Mid-Market lending |
||
| style="text-align:right" | 10 |
| style="text-align:right" | 10 |
||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
| style="text-align: |
| style="text-align:left" | - Strong diversification with €8m average ticket<br/>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
||
|- |
|- |
||
| style="text-align:left" | Other |
| style="text-align:left" | Other |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 0% |
| style="text-align:right" | 0% |
||
| style="text-align: |
| style="text-align:left" | |
||
|- |
|- |
||
! style="text-align:left" | Total Structured and Private Credit Assets |
|||
! class="col-s" style="text-align:right" | 69 |
|||
! class="col-s" style="text-align:right" | 15% |
|||
! style="text-align:left" | o/w 54% participating |
|||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=G/A: General Account}} |
|||
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>. |
|||
=== Investment portfolio | Fixed |
=== Investment portfolio | Fixed Income reinvestment === |
||
==== FY25 Fixed Income Reinvestment ==== |
|||
{{chunk|doc=snjra2xp9r|c=97|p=35}} |
|||
====== FY25 Fixed Income Reinvestment ====== |
|||
[Chart/image description: ] |
|||
A donut chart showing the breakdown of [[Definition:Full year 2025|FY25]] Fixed Income Reinvestment, totaling Euro 57 billion. |
|||
* Government bonds & related (dark blue): 32% |
|||
* Investment grade credit (medium blue): 40% |
|||
* ABS/CLO/IG fund financing (light blue-grey): 21% |
|||
* Below investment grade credit (lightest blue): 7% |
|||
{{chunk|doc=snjra2xp9r|c=98|p=35}} |
|||
====== FY25 fixed income reinvestment allocation ====== |
|||
* Government bonds & related: 32% of allocation, with an average rating of AA. |
|||
* Investment grade credit: 40% of allocation, with an average rating of A. |
|||
* ABS/CLO/IG fund financing: 21% of allocation. |
|||
* Below investment grade credit: 7% of allocation. |
|||
==== FY25 Fixed Income Reinvestment Yield ==== |
|||
{{chunk|doc=snjra2xp9r|c=99|p=35}} |
|||
====== FY25 Fixed Income Reinvestment Yield ====== |
|||
[Chart/image description: ] |
|||
A bar chart showing reinvestment yields: |
|||
* Public fixed income: 3.5% |
|||
* Private & Structured fixed income: 4.7% |
|||
* Total fixed income: 3.9% |
|||
=== ▶ Euro 57 billion fixed income invested at 3.9% === |
|||
{{chunk|doc=snjra2xp9r|c=100|p=35}} |
|||
====== Fixed income portfolio characteristics ====== |
|||
* Average duration of 9 years |
|||
* EUR 19.7bn of Private & Structured Credit invested at 4.7% |
|||
* Private & Structured Credit includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY |
|||
* Gradual shift from alternative total return assets to Private & Structured credit |
|||
{{chunk|doc=snjra2xp9r|c=101|p=35}} |
|||
====== ▶ Euro 57 billion fixed income invested at 3.9% ====== |
|||
{{fn note|1=1|2=Government and Corporate bonds and related.}} |
|||
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}} |
|||
{{chunk|doc=snjra2xp9r|c=102|p=36}} |
|||
====== Debt and invested assets ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t10" class="wikitable" |
||
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup> |
|||
! style="text-align:left" | Asset mix |
|||
! class="col-s" style="text-align:right" | Share |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1. |
||
| style="text-align: |
| style="text-align:left" | Debt and Invested Assets |
||
| style="text-align:right" | p.31 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2. |
||
| style="text-align: |
| style="text-align:left" | Additional P&C disclosures |
||
| style="text-align:right" | p.36 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 3. |
||
| style="text-align: |
| style="text-align:left" | Additional IFRS17 disclosures |
||
| style="text-align:right" | p.41 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 4. |
||
| style="text-align: |
| style="text-align:left" | Sustainability |
||
| style="text-align:right" | p.44 |
|||
|} |
|} |
||
</div> |
</div> |
||
=== AXA XL Insurance | Large Commercial & Specialty business === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=103|p=37}} |
|||
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup> |
|||
====== Business diversification ====== |
|||
! style="text-align:left" | Fixed Income Type |
|||
! class="col-s" style="text-align:right" | Yield |
|||
* AXA XL Insurance is well diversified across lines of business and geographies. |
|||
|- |
|||
* AXA XL Insurance holds leading market positions across its lines of business. |
|||
| style="text-align:left" | Public fixed income |
|||
| style="text-align:right" | 3.5% |
|||
{{chunk|doc=snjra2xp9r|c=104|p=37}} |
|||
|- |
|||
====== AXA XL Insurance | Large Commercial & Specialty business ====== |
|||
| style="text-align:left" | Private & Structured fixed income |
|||
| style="text-align:right" | 4.7% |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left; font-weight:bold" | Total fixed income |
|||
Left column: Two donut charts. |
|||
| style="text-align:right; font-weight:bold" | 3.9% |
|||
Top chart: Title "[[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by line of business", center value "$19bn". Segments: Casualty (35%), Property (29%), Specialty (19%), Professional lines¹ (17%). |
|||
|} |
|||
Bottom chart: Title "FY25 GWP by geography", center value "$19bn". Segments: Americas (46%), Europe & APAC (35%), UK & Lloyds (19%). |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=105|p=37}} |
|||
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup> |
|||
====== AXA XL Insurance market positions ====== |
|||
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup> |
|||
** Average duration of 9 years <sup>p. 35</sup> |
|||
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup> |
|||
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup> |
|||
* AXA XL Insurance holds leading market positions across lines, ranking in the top 3 globally for Multinational Programs, Marine, and Fine Art & Specie. |
|||
=== Table of contents === |
|||
{{chunk|doc=snjra2xp9r|c=106|p=37}} |
|||
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup> |
|||
====== AXA XL Insurance profitability vs. ex-price growth ====== |
|||
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup> |
|||
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup> |
|||
* ''Sustainability'' on page 44 <sup>p. 36</sup> |
|||
* A scatter plot illustrates profitability versus ex-price growth for various lines of business. |
|||
=== AXA XL Insurance | Large Commercial & Specialty business === |
|||
* Property shows high profitability and high ex-price growth. |
|||
* Specialty shows moderate profitability and moderate ex-price growth. |
|||
* Casualty shows moderate profitability and low ex-price growth. |
|||
* Professional lines shows low profitability and low ex-price growth. |
|||
=== Top 3 globally === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=107|p=37}} |
|||
|+ FY25 GWP by line of business <sup>p. 37</sup> |
|||
====== Global P&C Commercial Lines ====== |
|||
! style="text-align:left" | Line of business |
|||
! class="col-s" style="text-align:right" | Share |
|||
* AXA XL is a global leader in P&C Commercial Lines. |
|||
|- |
|||
* AXA XL is the #1 global insurer for Multinational Programs. |
|||
| style="text-align:left" | Casualty |
|||
* AXA XL is the #1 global insurer for Marine. |
|||
| style="text-align:right" | 35% |
|||
* AXA XL is the #1 global insurer for Fine Art & Specie. |
|||
|- |
|||
| style="text-align:left" | Property |
|||
=== Managing the cycle to deliver consistent profitability === |
|||
| style="text-align:right" | 29% |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=108|p=37}} |
|||
| style="text-align:left" | Specialty |
|||
====== profitability ex-price growth ====== |
|||
| style="text-align:right" | 19% |
|||
|- |
|||
* Profitability Ex-price growth: 0.5% in 2023; 0.5% in 2022; 0.5% in 2021; 0.5% in 2020; 0.5% in 2019 |
|||
| style="text-align:left" | Professional lines (including Cyber) |
|||
| style="text-align:right" | 17% |
|||
{{chunk|doc=snjra2xp9r|c=109|p=37}} |
|||
|} |
|||
====== Managing the cycle to deliver consistent profitability ====== |
|||
</div> |
|||
<div |
<div class="ed-chart-desc"> |
||
[Chart/image description:] |
|||
{| class="wikitable fintable" |
|||
Scatter plot with Y-axis labeled "Profitability" and X-axis labeled "Ex-price growth (%)". Four bubbles: "Property" (high profitability, high ex-price growth), "Specialty" (medium-high profitability, medium ex-price growth), "Casualty" (medium profitability, low ex-price growth), "Professional lines" (low profitability, very low ex-price growth). |
|||
|+ FY25 GWP by geography <sup>p. 37</sup> |
|||
! style="text-align:left" | Geography |
|||
! class="col-s" style="text-align:right" | Share |
|||
|- |
|||
| style="text-align:left" | Americas |
|||
| style="text-align:right" | 46% |
|||
|- |
|||
| style="text-align:left" | Europe & APAC |
|||
| style="text-align:right" | 35% |
|||
|- |
|||
| style="text-align:left" | UK & Lloyds |
|||
| style="text-align:right" | 19% |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=110|p=37}} |
|||
<div style="overflow-x:auto"> |
|||
====== Managing the cycle to deliver consistent profitability ====== |
|||
{| class="wikitable" |
|||
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup> |
|||
{{fn note|1=1|2=Including Cyber}} |
|||
! style="text-align:left" | Line of business |
|||
{{fn note|1=2|2=Source: McKinsey}} |
|||
! class="col-m" style="text-align:right" | Profitability |
|||
{{fn note|1=3|2=Source: Aon, Guy Carpenter, and Global Market Insights}} |
|||
! class="col-m" style="text-align:right" | Ex-price growth |
|||
{{fn note|1=4|2=Source: Industry Research Biz (January 2026)}} |
|||
|- |
|||
| style="text-align:left" | Property |
|||
== P&C | Focus on Reserves == |
|||
| class="col-m" style="text-align:right" | high |
|||
| class="col-m" style="text-align:right" | high |
|||
=== Claims reserves ratio === |
|||
|- |
|||
| style="text-align:left" | Specialty |
|||
{{chunk|doc=snjra2xp9r|c=111|p=38}} |
|||
| class="col-m" style="text-align:right" | medium-high |
|||
====== Claims reserves ratio definition ====== |
|||
| class="col-m" style="text-align:right" | medium-high |
|||
|- |
|||
* The claims reserves ratio is calculated as Net undiscounted claims reserves divided by Net earned premiums. |
|||
| style="text-align:left" | Casualty |
|||
| class="col-m" style="text-align:right" | medium |
|||
{{chunk|doc=snjra2xp9r|c=112|p=38}} |
|||
| class="col-m" style="text-align:right" | medium |
|||
====== Claims reserves ratio ====== |
|||
|- |
|||
| style="text-align:left" | Professional lines |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
| class="col-m" style="text-align:right" | lower |
|||
Bar chart showing Claims reserves ratio for FY18 to [[Definition:Full year 2025|FY25]]. |
|||
|} |
|||
- IFRS4 period (light blue bars): |
|||
- FY18: 179% |
|||
- FY19: 185% |
|||
- FY20: 193% |
|||
- FY21: 188% |
|||
- FY22: 189% |
|||
- IFRS17 period (dark blue bars): |
|||
- FY22: 198% |
|||
- FY23: 195% |
|||
- [[Definition:Full year 2024|FY24]]: 180% |
|||
- FY25: 175% |
|||
</div> |
</div> |
||
=== Technical reserves ratio === |
|||
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup> |
|||
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>: |
|||
** Multinational Programs <sup>p. 37</sup> |
|||
** Marine <sup>p. 37</sup> |
|||
** Fine Art & Specie <sup>p. 37</sup> |
|||
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup> |
|||
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup> |
|||
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup> |
|||
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup> |
|||
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup> |
|||
{{chunk|doc=snjra2xp9r|c=113|p=38}} |
|||
=== P&C | Focus on reserves === |
|||
====== Net undiscounted technical reserves ratio ====== |
|||
* Net undiscounted technical reserves are presented as a ratio to Net earned premiums. |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=114|p=38}} |
|||
|+ Claims and technical reserves ratios <sup>p. 38</sup> |
|||
====== Technical reserves ratio ====== |
|||
! style="text-align:left" | % |
|||
! class="col-s" style="text-align:right" | FY18 |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
! class="col-s" style="text-align:right" | FY20 |
|||
Bar chart showing Technical reserves ratio for FY18 to [[Definition:Full year 2025|FY25]]. |
|||
! class="col-s" style="text-align:right" | FY21 |
|||
- IFRS4 period (light blue bars): |
|||
! class="col-s" style="text-align:right" | FY22 |
|||
- FY18: 213% |
|||
! class="col-s" style="text-align:right" | FY23 |
|||
- FY19: 227% |
|||
! class="col-s" style="text-align:right" | FY24 |
|||
- FY20: 233% |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
- FY21: 226% |
|||
|- |
|||
- FY22: 227% |
|||
| style="text-align:left" | Claims reserves ratio (IFRS4 basis) |
|||
- IFRS17 period (dark blue bars): |
|||
| style="text-align:right" | 179 |
|||
- FY22: 234% |
|||
| style="text-align:right" | 185 |
|||
- FY23: 232% |
|||
| style="text-align:right" | 193 |
|||
- [[Definition:Full year 2024|FY24]]: 216% |
|||
| style="text-align:right" | 188 |
|||
- FY25: 210% |
|||
| style="text-align:right" | 189 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Claims reserves ratio (IFRS17 basis) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 198 |
|||
| style="text-align:right" | 195 |
|||
| style="text-align:right" | 180 |
|||
| style="text-align:right" | 175 |
|||
|- |
|||
| style="text-align:left" | Technical reserves ratio (IFRS4 basis) |
|||
| style="text-align:right" | 213 |
|||
| style="text-align:right" | 227 |
|||
| style="text-align:right" | 233 |
|||
| style="text-align:right" | 226 |
|||
| style="text-align:right" | 227 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Technical reserves ratio (IFRS17 basis) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 234 |
|||
| style="text-align:right" | 232 |
|||
| style="text-align:right" | 216 |
|||
| style="text-align:right" | 210 |
|||
|} |
|||
</div> |
</div> |
||
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=115|p=38}} |
|||
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 === |
|||
====== Technical reserves ratio ====== |
|||
{{fn note|1=1|2=Includes net undiscounted claims reserves and unearned premium reserves.}} |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 === |
|||
|+ Insurance segment occurrence protection <sup>p. 39</sup> |
|||
! style="text-align:left" | EUR |
|||
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program === |
|||
! class="col-s" style="text-align:right" | Retention |
|||
! class="col-m" style="text-align:right" | Capacity |
|||
{{chunk|doc=snjra2xp9r|c=116|p=39}} |
|||
|- |
|||
====== Currency ====== |
|||
| style="text-align:left" | EU Windstorm |
|||
| style="text-align:right" | 600m |
|||
* All figures are in EUR. |
|||
| style="text-align:right" | 4.0bn |
|||
|- |
|||
{{chunk|doc=snjra2xp9r|c=117|p=39}} |
|||
| style="text-align:left" | Europe Flood |
|||
====== P&C | 2026 Simplified Group Nat Cat Reinsurance Program ====== |
|||
| style="text-align:right" | 450m |
|||
| style="text-align:right" | 2.1bn |
|||
<div class="ed-chart-desc"> |
|||
|- |
|||
[Chart/image description:] |
|||
| style="text-align:left" | Europe Earthquake |
|||
Bar chart showing the [[Definition:Year 2026|2026]] Simplified Group Nat Cat Reinsurance Program. Two sections are shown: "Insurance segment (occurrence protection)" on the left, and "Reinsurance segment (illustrative)" on the right. |
|||
| style="text-align:right" | 400m |
|||
| style="text-align:right" | 2.1bn |
|||
|- |
|||
| style="text-align:left" | NA Hurricane |
|||
| style="text-align:right" | 600m |
|||
| style="text-align:right" | 1.2bn |
|||
|- |
|||
| style="text-align:left" | NA Earthquake |
|||
| style="text-align:right" | 600m |
|||
| style="text-align:right" | 1.2bn |
|||
|- |
|||
| style="text-align:left" | Per other perils |
|||
| style="text-align:right" | 400m |
|||
| style="text-align:right" | Varies by peril type |
|||
|} |
|||
</div> |
</div> |
||
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=118|p=39}} |
|||
* (diagram) ''Reinsurance segment'' (illustrative): |
|||
====== Insurance segment peril categories ====== |
|||
* Covered via ''Alternative Capital & Cat Bonds'' <sup>p. 39</sup> |
|||
* The Insurance segment includes six peril categories with specified Capacity and Retention levels: |
|||
** EU Windstorm: Capacity EUR 4.0bn; Retention EUR 600m |
|||
** Europe Flood: Capacity EUR 2.1bn; Retention EUR 450m |
|||
** Europe Earthquake: Capacity EUR 2.1bn; Retention EUR 400m |
|||
** NA Hurricane: Capacity EUR 1.2bn; Retention EUR 600m |
|||
** NA Earthquake: Capacity EUR 1.2bn; Retention EUR 600m |
|||
** Per other perils: Capacity ~EUR 0.8bn; Retention EUR 400m |
|||
{{chunk|doc=snjra2xp9r|c=119|p=39}} |
|||
====== Reinsurance segment and retention levels ====== |
|||
* The Reinsurance segment includes "Alternative Capital & Cat Bonds". |
|||
* This segment has a value of EUR 1.0bn. |
|||
* Retention levels are expected to remain stable in [[Definition:Year 2026|2026]] compared to 2025. |
|||
{{chunk|doc=snjra2xp9r|c=120|p=39}} |
|||
====== P&C | 2026 Simplified Group Nat Cat Reinsurance Program ====== |
|||
{{fn note|1=1|2=Excludes local reinsurance covers; 2. Varying retention between MX and NA (400m MX, 600m NA); 3. Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.}} |
|||
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 === |
||
{{chunk|doc=snjra2xp9r|c=121|p=40}} |
|||
====== Group underlying earnings deviation to average Nat Cat charges ====== |
|||
* Group [[Definition:Underlying earnings|underlying earnings]] deviation to average Nat Cat charges in [[Definition:Year 2026|2026]], net of reinsurance and post-tax, shows a median (50th percentile) of EUR 0bn. |
|||
* More severe years (negative deviation in approximately 40% of cases) include: |
|||
** 1/20y (95th percentile): EUR -1.2bn deviation. |
|||
** 1/10y (90th percentile): EUR -0.8bn deviation. |
|||
** 1/5y (80th percentile): EUR -0.4bn deviation. |
|||
* Less severe years (positive deviation in approximately 60% of cases) include: |
|||
** 1/5y (20th percentile): EUR +0.1bn deviation. |
|||
** 1/10y (10th percentile): EUR +0.5bn deviation. |
|||
** 1/20y (5th percentile): EUR +0.7bn and EUR +0.8bn deviation. |
|||
{{chunk|doc=snjra2xp9r|c=122|p=40}} |
|||
====== Average expected Nat Cat charges ====== |
|||
* Average Expected Nat Cat charges net of reinsurance, pre-tax, are EUR 2.6bn for 2025 and EUR 2.7bn for [[Definition:Year 2026|2026]]. |
|||
* The estimated impact on GEP for both 2025 and 2026 is approximately 4.5%. |
|||
* Natural catastrophe cost is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. |
|||
* Deviation is compared to a normalized level, which represents costs associated with natural catastrophes expected in an average year (approximately 4.5 points of estimated [[Definition:Full year 2025|FY25]] GEP, undiscounted and net of reinsurance). |
|||
{{chunk|doc=snjra2xp9r|c=123|p=41}} |
|||
====== Additional P&C disclosures ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t11" class="wikitable" |
||
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 <sup>p. 40</sup> |
|||
! style="text-align:left" | Return period / probability percentile |
|||
! class="col-s" style="text-align:right" | EUR billion |
|||
|- |
|||
| style="text-align:left" | 1/20y (95th percentile) |
|||
| style="text-align:right" | -1.2 |
|||
|- |
|||
| style="text-align:left" | 1/10y (90th percentile) |
|||
| style="text-align:right" | -0.8 |
|||
|- |
|||
| style="text-align:left" | 1/5y (80th percentile) |
|||
| style="text-align:right" | -0.4 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1. |
||
| style="text-align: |
| style="text-align:left" | Debt and Invested Assets |
||
| style="text-align:right" | p.31 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2. |
||
| style="text-align: |
| style="text-align:left" | Additional P&C disclosures |
||
| style="text-align:right" | p.36 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 3. |
||
| style="text-align: |
| style="text-align:left" | Additional IFRS17 disclosures |
||
| style="text-align:right" | p.41 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 4. |
||
| style="text-align: |
| style="text-align:left" | Sustainability |
||
| style="text-align:right" | p.44 |
|||
|} |
|} |
||
</div> |
</div> |
||
=== P&C | Margin Analysis === |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable" |
|||
{{chunk|doc=snjra2xp9r|c=124|p=42}} |
|||
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup> |
|||
====== P&C | Margin Analysis ====== |
|||
! style="text-align:left" | Year |
|||
! class="col-s" style="text-align:right" | EUR billion |
|||
<div class="ed-chart-desc"> |
|||
! class="col-s" style="text-align:right" | Estimated impact on GEP |
|||
[Chart/image description:] |
|||
|- |
|||
The image displays a financial margin analysis diagram for Property & Casualty (P&C) insurance, structured as a flow from "Technical Result" to "Financial Result" and finally to "[[Definition:Underlying earnings|Underlying Earnings]] before tax" and "Underlying Earnings". The entire diagram is labeled "In Euro million (pre-tax)". |
|||
| style="text-align:left" | 2025 |
|||
| class="col-s" style="text-align:right" | 2.6 |
|||
| class="col-s" style="text-align:right" | ca. 4.5% |
|||
|- |
|||
| style="text-align:left" | 2026 |
|||
| class="col-s" style="text-align:right" | 2.7 |
|||
| class="col-s" style="text-align:right" | ca. 4.5% |
|||
|} |
|||
</div> |
</div> |
||
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>. |
|||
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>. |
|||
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup> |
|||
{{chunk|doc=snjra2xp9r|c=125|p=42}} |
|||
=== Table of contents === |
|||
====== P&C technical result components ====== |
|||
* Technical Result components: |
|||
* ''Debt and Invested Assets'' <sup>p. 31</sup> |
|||
** Current Accident Year Undiscounted Technical Margin: EUR 2,778 ([[Definition:Full year 2025|FY25]]); +EUR 707 change. |
|||
* ''Additional P&C disclosures'' <sup>p. 36</sup> |
|||
*** Gross Earned Premiums: EUR 57,656 (+6%). |
|||
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup> |
|||
*** Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt). |
|||
* ''Sustainability'' <sup>p. 44</sup> |
|||
*** Nat Cats within Combined Ratio: 3.4% (-0.4pt). |
|||
** Current Accident Year Discounting: EUR 2,009 (FY25); +EUR 115 change. |
|||
*** Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt). |
|||
*** Current Accident Year Net Claims reserves: EUR 19.0bn. |
|||
*** Duration: 4.0 years. |
|||
*** Current Accident Year Discount rate: 2.8%. |
|||
** Prior Years' Reserve Development (PYD): EUR 622 (FY25); -EUR 341 change. |
|||
*** PYD ratio: -1.1% (+0.7pt). |
|||
* Sensitivity of FY25 Current Accident Year discount rate changes: +25bps leads to +EUR 0.2bn; -25bps leads to -EUR 0.2bn. |
|||
** This sensitivity refers to a parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve. |
|||
{{chunk|doc=snjra2xp9r|c=126|p=42}} |
|||
=== P&C | Margin analysis === |
|||
====== P&C financial result components ====== |
|||
* Financial Result components: |
|||
<div style="overflow-x:auto"> |
|||
** Investment Income: EUR 3,988 ([[Definition:Full year 2025|FY25]]); +EUR 435 change. |
|||
{| class="wikitable fintable" |
|||
*** FY25 Average Assets: EUR 115bn. |
|||
|+ P&C margin analysis and underlying earnings FY25 <sup>p. 42</sup> |
|||
*** Asset book yield: 3.5%. |
|||
! style="text-align:left" | EUR million |
|||
*** FY25 Reinvestment yield on fixed income assets: 4.3%. |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
** Insurance Finance Expenses: -EUR 1,358 (FY25); -EUR 235 change. |
|||
! class="col-s" style="text-align:right" | Change |
|||
*** [[Definition:Full year 2024|FY24]] Reserves at locked-in rate: EUR 71bn. |
|||
|- |
|||
*** Liability book yield: 1.9%. |
|||
| style="text-align:left" | ''Current Accident Year Undiscounted Technical Margin'' |
|||
* 2026e Insurance Finance Expenses (pre-tax): ~EUR -1.4bn. |
|||
| style="text-align:right" | 2,778 |
|||
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount: +25bps leads to ~EUR -50m; -25bps leads to ~+EUR 50m. |
|||
| style="text-align:right" | +707 |
|||
|- |
|||
| style="text-align:left" | ''Current Accident Year Discounting'' |
|||
| style="text-align:right" | 2,009 |
|||
| style="text-align:right" | +115 |
|||
|- |
|||
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)'' |
|||
| style="text-align:right" | 622 |
|||
| style="text-align:right" | -341 |
|||
|- |
|||
| style="text-align:left" | ''Investment Income'' |
|||
| style="text-align:right" | 3,988 |
|||
| style="text-align:right" | +435 |
|||
|- |
|||
| style="text-align:left" | ''Insurance Finance Expenses'' |
|||
| style="text-align:right" | -1,358 |
|||
| style="text-align:right" | -235 |
|||
|- |
|||
| style="text-align:left" | ''Underlying Earnings before tax'' |
|||
| style="text-align:right" | 8,040 |
|||
| style="text-align:right" | +681 |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | -2,060 |
|||
| style="text-align:right" | -169 |
|||
|- |
|||
| style="text-align:left" | Affiliates, Minority interests & Other |
|||
| style="text-align:right" | -108 |
|||
| style="text-align:right" | -10 |
|||
|- |
|||
| style="text-align:left" | ''Underlying Earnings'' |
|||
| style="text-align:right" | 5,872 |
|||
| style="text-align:right" | +501 |
|||
|} |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=127|p=42}} |
|||
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup> |
|||
====== P&C underlying earnings ====== |
|||
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup> |
|||
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup> |
|||
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup> |
|||
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup> |
|||
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup> |
|||
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup> |
|||
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup> |
|||
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve): |
|||
** +25bps: +EUR 0.2bn <sup>p. 42</sup> |
|||
** -25bps: -EUR 0.2bn <sup>p. 42</sup> |
|||
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup> |
|||
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup> |
|||
* [[Definition:Underlying earnings|Underlying Earnings]] before tax ([[Definition:Full year 2025|FY25]]): EUR 8,040; +EUR 681 change. |
|||
=== L&H | Margin analysis === |
|||
* Tax: -EUR 2,060; -EUR 169 change. |
|||
* Affiliates, Minority interests & Other: -EUR 108; -EUR 10 change. |
|||
* Underlying Earnings (FY25): EUR 5,872; +EUR 501 change. |
|||
* Growth vs. [[Definition:Full year 2024|FY24]] (at constant [[Definition:Foreign exchange|FX]]): +9%. |
|||
* The diagram uses dashed lines and plus signs (+) to indicate summation between components. |
|||
=== L&H | Margin Analysis === |
|||
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>. |
|||
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>. |
|||
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>. |
|||
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>. |
|||
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>. |
|||
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>. |
|||
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>. |
|||
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>. |
|||
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>. |
|||
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>. |
|||
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>. |
|||
{{chunk|doc=snjra2xp9r|c=128|p=43}} |
|||
<div style="overflow-x:auto"> |
|||
====== Scope impact ====== |
|||
{| class="wikitable fintable" |
|||
|+ Technical and financial results in Euro million, pre-tax <sup>p. 43</sup> |
|||
! style="text-align:left" | Technical and Financial Results |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
! class="col-s" style="text-align:right" | Change |
|||
|- |
|||
| style="text-align:left" | Short-term Technical Margin |
|||
| style="text-align:right" | 479 |
|||
| style="text-align:right" | +60 |
|||
|- |
|||
| style="text-align:left" | Long-term Technical Margin |
|||
| style="text-align:right" | 2,804 |
|||
| style="text-align:right" | +156 |
|||
|- |
|||
| style="text-align:left" | Investment Income (non-VFA only) |
|||
| style="text-align:right" | 2,484 |
|||
| style="text-align:right" | -1 |
|||
|- |
|||
| style="text-align:left" | Insurance Finance Expenses (non-VFA only) |
|||
| style="text-align:right" | -1,538 |
|||
| style="text-align:right" | -9 |
|||
|} |
|||
</div> |
|||
* Includes scope impact. |
|||
<div style="overflow-x:auto"> |
|||
{| class="wikitable fintable" |
|||
{{chunk|doc=snjra2xp9r|c=129|p=43}} |
|||
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup> |
|||
====== L&H | Margin Analysis ====== |
|||
! style="text-align:left" | Underlying Earnings |
|||
! class="col-s" style="text-align:right" | FY25 |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
|- |
|||
Flowchart showing the components of Life & Health Margin Analysis, leading to [[Definition:Underlying earnings|Underlying Earnings]]. |
|||
| style="text-align:left" | Underlying Earnings before tax |
|||
| style="text-align:right" | 4,229 |
|||
| style="text-align:right" | +205 |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | -800 |
|||
| style="text-align:right" | 65 |
|||
|- |
|||
| style="text-align:left" | Affiliates, Minority interests & Other |
|||
| style="text-align:right" | 72 |
|||
| style="text-align:right" | -51 |
|||
|- |
|||
| style="text-align:left" | Underlying Earnings |
|||
| style="text-align:right" | 3,501 |
|||
| style="text-align:right" | +219 |
|||
|} |
|||
</div> |
</div> |
||
{{chunk|doc=snjra2xp9r|c=130|p=43}} |
|||
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>. |
|||
====== Technical and Financial Results ====== |
|||
* Short-term Technical Margin: EUR 479m (change: +EUR 60m) |
|||
* Gross Earned Premiums: EUR 17,416m (change: +10%) |
|||
* All Year Combined Ratio: 97.2% (change: -0.1pts); includes recapture of Laya |
|||
* Long-term Technical Margin: EUR 2,804m (change: +EUR 156m) |
|||
* CSM release: EUR 2,954m (change: +EUR 215m) |
|||
* Technical experience: -EUR 150m (change: -EUR 58m) |
|||
* Investment Income (non-VFA only): EUR 2,484m (change: -EUR 1m) |
|||
* [[Definition:Full year 2025|FY25]] Average Assets: EUR 98bn |
|||
* Asset book yield: 2.5% |
|||
* FY25 Reinvestment yield: 3.8% |
|||
* Insurance Finance Expenses (non-VFA only): -EUR 1,538m (change: -EUR 9m) |
|||
* [[Definition:Full year 2024|FY24]] Reserves at locked-in rate: EUR 62bn |
|||
* Liability book yield: 2.5% |
|||
{{chunk|doc=snjra2xp9r|c=131|p=43}} |
|||
====== Underlying Earnings ====== |
|||
* [[Definition:Underlying earnings|Underlying Earnings]] before tax: EUR 4,229m (change: +EUR 205m) |
|||
* Tax: -EUR 800m (change: +EUR 65m) |
|||
* Affiliates, Minority interests & Other: EUR 72m (change: -EUR 51m) |
|||
* Underlying Earnings: EUR 3,501m (change: +EUR 219m) |
|||
* Underlying Earnings growth vs. [[Definition:Full year 2024|FY24]] (at constant [[Definition:Foreign exchange|FX]]): +7% |
|||
{{chunk|doc=snjra2xp9r|c=132|p=43}} |
|||
====== Life & Health FY25 CSM by sensitivities ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t12" class="wikitable fintable" |
||
|+ Life & Health FY25 CSM key sensitivities in Euro billion <sup>p. 43</sup> |
|||
! style="text-align:left" | Sensitivity |
|||
! class="col-s" style="text-align:right" | Impact |
|||
|- |
|- |
||
| style="text-align:left" | Baseline |
| style="text-align:left" | Baseline |
||
| Line 1,684: | Line 1,666: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}} |
|||
=== Table of contents === |
|||
== Table of contents == |
|||
* ''Debt and Invested Assets'' <sup>p. 31</sup> |
|||
* ''Additional P&C disclosures'' <sup>p. 36</sup> |
|||
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup> |
|||
* ''Sustainability'' <sup>p. 44</sup> |
|||
{{chunk|doc=snjra2xp9r|c=133|p=44}} |
|||
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
|||
====== Table of contents ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t13" class="wikitable" |
||
|+ ESG targets and achievements <sup>p. 45</sup> |
|||
! style="text-align:left" | Category |
|||
! class="col-m" style="text-align:right" | Target |
|||
! class="col-m" style="text-align:right" | Achieved in 2025 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 1. |
||
| |
| style="text-align:left" | Debt and Invested Assets |
||
| |
| style="text-align:right" | p.31 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 2. |
||
| |
| style="text-align:left" | Additional P&C disclosures |
||
| |
| style="text-align:right" | p.36 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 3. |
||
| |
| style="text-align:left" | Additional IFRS17 disclosures |
||
| |
| style="text-align:right" | p.41 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | 4. |
||
| |
| style="text-align:left" | Sustainability |
||
| |
| style="text-align:right" | p.44 |
||
|} |
|||
</div> |
|||
=== Expanding AXA's role in society: AXA for Progress Index 1 === |
|||
=== Expanding AXA’s role in society: AXA for Progress Index === |
|||
{{chunk|doc=snjra2xp9r|c=134|p=45}} |
|||
====== Climate transition financing and community resilience financing by target and result ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t14" class="wikitable" |
|||
|- |
|- |
||
! style="text-align:left" | Target |
|||
! style="text-align:right" | 2025 Result |
|||
| class="col-m" style="text-align:right" | 20.6m |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | |
||
|} |
|||
| class="col-m" style="text-align:right" | >80,000 employees by 2026 |
|||
</div> |
|||
| class="col-m" style="text-align:right" | 46,420 |
|||
€5bn{{fn ref|2}}<br/> |
|||
in climate transition financing per year |
|||
</td> |
|||
<td>€6.4bn</td> |
|||
</tr> |
|||
<tr> |
|||
<td> |
|||
>€500m{{fn ref|2}}<br/> |
|||
in community resilience financing per year |
|||
</td> |
|||
<td>€1.4bn</td> |
|||
</tr> |
|||
</table> |
|||
{{chunk|doc=snjra2xp9r|c=135|p=45}} |
|||
====== Target by 2025 Result ====== |
|||
<div style="overflow-x:auto"> |
|||
{| id="t15" class="wikitable" |
|||
|- |
|- |
||
! style="text-align:left" | Target |
|||
! style="text-align:right" | 2025 Result |
|||
| class="col-m" style="text-align:right" | -64% against 2019 |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | |
||
| class="col-m" style="text-align:right" | 50% of employees by 2026 |
|||
| class="col-m" style="text-align:right" | 56% |
|||
|} |
|} |
||
</div> |
</div> |
||
€6bn{{fn ref|3}}<br/> |
|||
in P&C [[Definition:Gross written premiums|GWP]] to support transition underwriting (cumulative 2024-[[Definition:Year 2026|2026]]) |
|||
</td> |
|||
<td>€4.6bn</td> |
|||
</tr> |
|||
<tr> |
|||
<td> |
|||
>20,000{{fn ref|4}}<br/> |
|||
climate adaptation solutions & services (cumulative 2024-2026)<br/> |
|||
Target revised in 2025 |
|||
</td> |
|||
<td> |
|||
19,698<br/> |
|||
Cumulative 2024-2025 |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td> |
|||
>20m{{fn ref|5|2=5. Low-income to mass market segments in emerging markets and modest income segments in mature markets.}}<br/> |
|||
inclusive insurance customers by 2026 |
|||
</td> |
|||
<td>20.6m</td> |
|||
</tr> |
|||
</table> |
|||
{{chunk|doc=snjra2xp9r|c=136|p=45}} |
|||
=== Sustainability Performance & Ratings === |
|||
====== Target by 2025 Result ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t16" class="wikitable" |
||
|+ ESG ratings <sup>p. 46</sup> |
|||
! style="text-align:left" | Rating Agency |
|||
! class="col-s" style="text-align:right" | Score |
|||
|- |
|- |
||
! style="text-align:left" | Target |
|||
! style="text-align:right" | 2025 Result |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | |
||
| class="col-s" style="text-align:right" | AAA |
|||
|- |
|||
| style="text-align:left" | CDP |
|||
| class="col-s" style="text-align:right" | B |
|||
|- |
|||
| style="text-align:left" | Morningstar Sustainalytics |
|||
| class="col-s" style="text-align:right" | 17.0 - Low risk |
|||
|- |
|||
| style="text-align:left" | FTSE Russell |
|||
| class="col-s" style="text-align:right" | 4.3/5 |
|||
|} |
|} |
||
</div> |
</div> |
||
>80,000{{fn ref|6|2=6. Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}}<br/> |
|||
AXA Group employees trained on climate adaptation by [[Definition:Year 2026|2026]] |
|||
</td> |
|||
<td>46,420</td> |
|||
</tr> |
|||
<tr> |
|||
<td> |
|||
Contribute to Net-Zero<br/> |
|||
-50%{{fn ref|7|2=7. Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030<br/> |
|||
in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=8. Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}} |
|||
</td> |
|||
<td> |
|||
-64%<br/> |
|||
Reduction against 2019 |
|||
</td> |
|||
</tr> |
|||
<tr> |
|||
<td> |
|||
50%<br/> |
|||
Percentage of AXA Group employees engaged in volunteering activities by 2026 |
|||
</td> |
|||
<td>56%</td> |
|||
</tr> |
|||
</table> |
|||
{{fn note|1=1|2=1. AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.}} |
|||
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>. |
|||
{{fn note|1=2|2=2. Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}} |
|||
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup> |
|||
{{fn note|1=3|2=3. Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.}} |
|||
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup> |
|||
{{fn note|1=4|2=4. Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaption solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from >9,000 to >20,000.}} |
|||
{{fn note|1=5|2=5. Low-income to mass market segments in emerging markets and modest income segments in mature markets.}} |
|||
{{fn note|1=6|2=6. Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}} |
|||
{{fn note|1=7|2=7. Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} |
|||
{{fn note|1=8|2=8. Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}} |
|||
== Sustainability Performance & Ratings == |
|||
=== S&P Global === |
|||
{{chunk|doc=snjra2xp9r|c=137|p=46}} |
|||
====== Dow Jones Best-in-Class indices ====== |
|||
* AXA achieved the 97th percentile in the Dow Jones Best-in-Class Europe & World indices for 2025. |
|||
{{chunk|doc=snjra2xp9r|c=138|p=46}} |
|||
====== S&P Global ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Logo of MSCI. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=139|p=46}} |
|||
====== S&P Global rating ====== |
|||
* 2025 score: AAA |
|||
{{chunk|doc=snjra2xp9r|c=140|p=46}} |
|||
====== S&P Global ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Logo of Morningstar Sustainalytics. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=141|p=46}} |
|||
====== ESG Risk Rating ====== |
|||
* 2025 ESG Risk Rating: 17.0 (Low risk) |
|||
{{chunk|doc=snjra2xp9r|c=142|p=46}} |
|||
====== S&P Global ====== |
|||
<div class="ed-chart-desc"> |
|||
[Chart/image description:] |
|||
Logo of FTSE Russell, An LSEG Business. |
|||
</div> |
|||
{{chunk|doc=snjra2xp9r|c=143|p=46}} |
|||
====== FTSE4Good Index Series Score ====== |
|||
* AXA's 2025 score in the FTSE4Good Index Series is 4.3/5. |
|||
=== QCDP === |
|||
{{chunk|doc=snjra2xp9r|c=144|p=46}} |
|||
====== CDP score ====== |
|||
* CDP 2025 score: B |
|||
{{chunk|doc=snjra2xp9r|c=145|p=46}} |
|||
====== QCDP ====== |
|||
{{fn note|1=1|2=The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.}} |
|||
=== Scope === |
=== Scope === |
||
{{chunk|doc=snjra2xp9r|c=146|p=47}} |
|||
* ''France'' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>. |
|||
====== Scope ====== |
|||
* ''Europe'' scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>. |
|||
* ''AXA XL'' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>. |
|||
=== Theme: Scope definitions === |
|||
* ''Asia, Africa & EME-LATAM'' scope includes: |
|||
** ''Asia'': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>. |
|||
** ''Africa'': Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>. |
|||
** ''EME-LATAM'': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to net income <sup>p. 47</sup>. |
|||
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>. |
|||
* ''Transversal & Other'' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>. |
|||
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>. |
|||
* ''Accounting standards'' comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>. |
|||
=== Glossary === |
=== Glossary === |
||
{{chunk|doc=snjra2xp9r|c=147|p=48}} |
|||
* ''Capital-light G/A products'': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup> |
|||
====== Glossary of financial terms ====== |
|||
* ''Contractual Service Margin (CSM)'': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup> |
|||
* ''CSM release'': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup> |
|||
* ''Economic variance'': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup> |
|||
* ''Financial result'': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup> |
|||
* ''Gross Written Premiums and Other Revenues (GWP & Other Revenues)'': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup> |
|||
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup> |
|||
* ''New Business Contractual Service Margin (NB CSM)'': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup> |
|||
* ''New Business Value margin (NBV margin)'': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup> |
|||
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup> |
|||
* ''Present value of expected premiums (PVEP)'': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup> |
|||
* ''Technical experience'': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup> |
|||
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup> |
|||
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%. |
|||
=== February 26, 2026 Thank you Full Year 2025 earnings === |
|||
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders. |
|||
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period. |
|||
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force. |
|||
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow. |
|||
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). |
|||
** Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities). |
|||
* New Business Value (NBV): the value of newly issued contracts during the current year. It consists of the sum of: |
|||
** the new business contractual service margin. |
|||
** the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals. |
|||
** the present value of the future profits of pure investment contracts accounted for under IFRS 9. |
|||
** net of the cost of reinsurance. |
|||
** taxes. |
|||
** minority interests. |
|||
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided. |
|||
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP. |
|||
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance. |
|||
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share. |
|||
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses. |
|||
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance. |
|||
=== February 26, 2026 Thank you Full Year 2025 Earnings === |
|||
{{chunk|doc=snjra2xp9r|c=148|p=49}} |
|||
== Abbreviations == |
|||
====== Thank you ====== |
|||
* Thank you |
|||
* ''AA'': Senior bond rating |
|||
* [[Definition:Full year 2025|Full Year 2025]] Earnings |
|||
* ''AAA'': Senior bond rating |
|||
* ''ABS'': Asset-Backed Securities |
|||
* ''AEP'': Aggregate Exceedance Probability |
|||
* ''AI'': Artificial Intelligence |
|||
* ''AMF'': Autorité des marchés financiers |
|||
* ''APAC'': Asia-Pacific |
|||
* ''AXA IM'': AXA Investment Managers |
|||
* ''AXA XL'': AXA Corporate Solutions and XL Catlin |
|||
* ''AY'': Accident Year |
|||
* ''BBA'': Benefit-Bearing Account |
|||
* ''CDP'': Carbon Disclosure Project |
|||
* ''CLO'': Collateralized Loan Obligation |
|||
* ''CRE'': Commercial Real Estate |
|||
* ''CSA'': Corporate Sustainability Assessment |
|||
* ''CSM'': Contractual Service Margin |
|||
* ''CY'': Calendar Year |
|||
* ''DPS'': Dividend Per Share |
|||
* ''EME'': Emerging Markets |
|||
* ''EOF'': Eligible Own Funds |
|||
* ''EPS'': Earnings Per Share |
|||
* ''ESG'': Environmental, Social, and Governance |
|||
* ''ESMA'': European Securities and Markets Authority |
|||
* ''EU'': European Union |
|||
* ''EUR'': Euro |
|||
* ''FX'': Foreign Exchange |
|||
* ''GAAP'': Generally Accepted Accounting Principles |
|||
* ''GBP'': Great British Pound |
|||
* ''GEP'': Gross Earned Premium |
|||
* ''GWP'': Gross Written Premiums |
|||
* ''HKD'': Hong Kong Dollar |
|||
* ''HY'': High Yield |
|||
* ''IFE'': Insurance Finance Expenses |
|||
* ''IFRS'': International Financial Reporting Standards |
|||
* ''IG'': Investment Grade |
|||
* ''JPY'': Japanese Yen |
|||
* ''LATAM'': Latin America |
|||
* ''LFL'': Like-for-Like |
|||
* ''LTV'': Loan-to-Value |
|||
* ''MSCI'': Morgan Stanley Capital International |
|||
* ''NA'': North America |
|||
* ''NB CSM'': New Business Contractual Service Margin |
|||
* ''NBV'': New Business Value |
|||
* ''NHG'': Nationale Hypotheek Garantie |
|||
* ''NPS'': Net Promoter Score |
|||
* ''OCI'': Other Comprehensive Income |
|||
* ''PAA'': Participating Account Agreement |
|||
* ''PE'': Private Equity |
|||
* ''PVEP'': Present Value of Expected Profits |
|||
* ''PYD'': Prior Years' Reserve Development |
|||
* ''RCG'': Reinsurance Capital Generation |
|||
* ''ROE'': Return on Equity |
|||
* ''SCR'': Solvency Capital Requirement |
|||
* ''SHE'': Shareholders' Equity |
|||
* ''SME'': Small and Medium-sized Enterprises |
|||
* ''TVOG'': Time Value of Options and Guarantees |
|||
* ''UEPS'': Underlying Earnings Per Share |
|||
* ''UK'': United Kingdom |
|||
* ''US'': United States |
|||
* ''VAT'': Value Added Tax |
|||
* ''VFA'': Variable Fee Approach |
|||
Revision as of 23:50, 21 July 2026
| Document info | |
|---|---|
| Document ID | snjra2xp9r |
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Earnings presentation |
| Document name | AXA Full Year 2025 Results Presentation |
| Publication date | 2026-02-26 |
| Language | English |
| Pages | 49 |
| Source | original URL |
| Transcript | wiki page |
| Data | data page |
This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
Full Year 2025 Earnings Presentation
Importantlegalinformationandcautionarystatementsconcerningforward-lookingstatementsandtheuseof non-gaapfinancialmeasures
Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures
[c. 1; p. 2]
Forward-looking statements and risks
- Certain statements in the document are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and non-historical information.
- Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could".
- Statements regarding expected underlying earnings per share ("UEPS") growth for 2026 are forward-looking and provide one-off guidance for the last year of the Group's current strategic plan.
- These statements are based on Management's current views and intentions and are subject to change.
- Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially.
- Each forward-looking statement is valid only at the date of the presentation.
- Important factors, risks, and uncertainties affecting AXA's business and/or results are described in Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 (the "2024 Universal Registration Document").
- AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations.
[c. 2; p. 2]
Non-GAAP financial measures (APMs)
- The presentation refers to non-GAAP financial measures, or alternative performance measures ("APMs"), used by Management to analyze operating trends, financial performance, and position.
- These APMs provide investors with additional information deemed useful and relevant by Management.
- Non-GAAP financial measures generally lack standardized meaning and may not be comparable to similarly labeled measures from other companies.
- APMs should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS.
- "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" are APMs as defined by ESMA's guidelines and the AMF's related position statement issued in 2015.
- AXA provides a reconciliation of APMs to the most closely related financial statement items (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ("AXA's 2025 Activity Report"), under the heading "USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES".
- Further information on non-GAAP financial measures is available in the Glossary of AXA's 2025 Activity Report.
- AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com).
[c. 3; p. 2]
Financial statements audit
- AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026.
- The financial statements are subject to completion of an audit procedure by AXA's statutory auditors.
[c. 4; p. 2]
Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures
[Chart/image description:] A small blue square logo with the word "AXA" in white text, where the "X" is stylized with a red slash.
[c. 5; p. 3]
Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures
[Chart/image description:] Decorative teal corner bracket graphic (top-right area of the content region)
[c. 6; p. 3]
Important legal information and cautionary statements concerning forward-looking statements and the use of non-gaap financial measures
[Chart/image description:] Decorative teal corner bracket graphic (bottom-left area of the content region)
[c. 7; p. 3]
FY25 presentation sections
- FY25 Highlights are on page 04, presented by Thomas Buberl, Group CEO.
- FY25 Business Performance is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
- FY25 Financial Performance is on page 13, presented by Alban de Mailly Nesle, Group CFO.
1 FY25 Highlights
[c. 8; p. 4]
CEO statement
- Thomas Buberl is the Group CEO.
Full Year 2025 | Excellent performance
[c. 9; p. 5]
- Revenues +6% vs. FY24
- Return on Equity (ROE) 16% in FY25
- Underlying EPS +8% vs. FY24
- Solvency II ratio 224% in FY25
- Dividend Per Share (DPS) growth +8%
- Annual share buyback of EUR 1.25bn
- Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
[c. 10; p. 5]
Full Year 2025 | Excellent performance
Executing the plan on growth, margin and efficiency
[c. 11; p. 6]
Executing the plan on growth, margin and efficiency
[Chart/image description:] Bar chart showing Underlying earnings in Euro billion for FY24 and FY25. - FY24: 8.1 (light blue bar) - FY25: 8.4 (dark blue bar) - Growth from FY24 to FY25 is labeled as +6%. - A callout box next to the FY25 bar states: +9% excluding AXA IM.
[c. 12; p. 6]
Organic growth and profitability
- Top line growth: +6%, balanced across lines
- P&C: +5%
- Life: +9%
- Health: +5%
- Record profitability achieved
- Margin expansion in P&C and L&H
- Efficiency improved
[c. 13; p. 6]
Business scaling and earnings
- Continued investments in growth and technology
- Consistent earnings growth while enhancing reserve prudence
Diversified franchise, well positioned in an attractive industry
Secular trends fueling demand across businesses
[c. 14; p. 7]
Secular trends fueling demand across businesses
[Chart/image description:] A central donut chart showing the FY23 gross written premium split, excluding AXA IM and holdings. The chart is divided into five segments: - Life: 33% - Health: 17% - Large & Specialty: 17% - SME & Mid-market: 16% - Retail: 17% The AXA logo is in the center of the donut. To the left of the chart is the text: "Protection gaps and emerging corporate risks". To the right of the chart is the text: "Demographics driving demand for private retirement and healthcare".
Our right to win
[c. 15; p. 7]
Our right to win
[Chart/image description:] Four horizontal capsules, each containing a checkmark icon and a key strength: - Leading brand & high customer NPS - Strong and diversified distribution - Technical expertise to price & underwrite risks - Scale offering cost advantage @@ORIG_0@@
Laying the foundation for the next plan
[c. 16; p. 8]
Strategic initiatives
- Clear tech and AI roadmap is driving efficiency.
- Enhancing capital allocation discipline.
Confidence in sustaining earnings growth
[c. 17; p. 8]
Building resilience
- GIE_AXA_Internal is focused on building resilience.
[c. 17; p. 9]
- Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
- Guillaume Borie presented on FY25 Business Performance.
Strong delivery across our businesses
[c. 18; p. 10]
| Gross written premiums | Underlying earnings | |
|---|---|---|
| France (27% of total GWP1) |
+6% to €31bn |
+7% to €2.2bn |
| Europe (38% of total GWP1) |
+6% to €43bn |
+9% to €3.5bn |
| AXA XL (17% of total GWP1) |
+4% to €19bn |
+9% to €1.9bn |
| Asia, Africa & EME-LATAM (18% of total GWP1) |
+13% to €20bn |
+6% to €1.5bn |
[c. 19; p. 10]
Strong delivery across our businesses
[Chart/image description:] A visual representation of the table above, showing four business segments (France, Europe, AXA XL, Asia, Africa & EME-LATAM) with their respective GWP and Underlying earnings growth percentages and absolute values, each row accompanied by a blue checkmark icon on the right.
[c. 20; p. 10]
Strong delivery across our businesses
P&C | Strong margins, confidence in sustaining growth
[c. 21; p. 11]
P&C | Strong margins, confidence in sustaining growth
[Chart/image description:] A donut chart titled "GWP" with a central value of "€58bn". The chart is divided into three segments: - "Retail" (light blue, largest segment) - "SME & Mid-market" (medium blue, second largest) - "AXA XL (Large & Specialty)" (dark blue, smallest segment) The segment "AXA XL (Large & Specialty)" has a superscript "1" next to "AXA XL".
[c. 22; p. 11]
P&C GWP
- P&C GWP increased +9% to EUR 5.9bn.
[c. 23; p. 11]
P&C | Strong margins, confidence in sustaining growth
[Chart/image description:] A table-like diagram with two main columns: "2025" and "Beyond 2025". Rows: - Row 1: "Retail and SME & Mid-market" — "Growing volumes while expanding margins" under 2025; "Investing to improve customer retention & expanding distribution footprint" under Beyond 2025. - Row 2: "AXA XL (Large & Specialty)" — "Profitable growth with stable margins" under 2025; "Capitalizing on attractive growth opportunities and continued cycle management" under Beyond 2025. Below the table, a plus icon is centered, followed by three rounded rectangular boxes: - "Continued progress on efficiency" - "Higher investment income" - "Data & AI to further enhance customer experience & technical excellence"
[c. 24; p. 11]
P&C | Strong margins, confidence in sustaining growth
L&H| Good momentum, well positioned to capture growth opportunities
[c. 25; p. 12]
L&H| Good momentum, well positioned to capture growth opportunities
[Chart/image description:] A donut chart labeled "€57bn GWP" in the center. The chart is divided into two segments: a dark blue segment labeled "Short-term" and a light blue segment labeled "Long-term". The dark blue segment occupies approximately one-third of the chart, while the light blue segment occupies the remaining two-thirds.
[c. 26; p. 12]
L&H| Good momentum, well positioned to capture growth opportunities
[Chart/image description:] A two-column table with headers "2025" and "Beyond 2025". Under "2025", two rows: "Long-term business" with text "Accelerating net flows in Savings at attractive margins", and "Short-term business" with text "Growing technical results while absorbing Mexico VAT impact". Under "Beyond 2025", two rows: "Capturing savings & retirement opportunity, sourcing best asset management products for our customers", and "Capitalizing on demand for health & protection while further improving our margins". Below the table, three rounded rectangular boxes: "Focus on cost reduction", "Increasing penetration of Protection riders in Savings offerings", and "Leveraging AI to reduce claims leakage & improve customer outcomes in Health". A blue circle with a white plus sign is centered below the table and above the three boxes. At the bottom left, text reads "Underlying earnings +7%1 to €3.5bn". At the bottom right, text reads "Full Year 2025 Earnings" next to an AXA logo.
[c. 27; p. 12]
Group CFO and FY25 Financial Performance
- GIE_AXA_Internal Alban de Mailly Nesle is the Group CFO for FY25 Financial Performance.
[c. 28; p. 12]
L&H| Good momentum, well positioned to capture growth opportunities
3
FY25 Financial Performance
[c. 29; p. 13]
Group CFO commentary
- Alban de Mailly Nesle is the Group CFO.
P&C| Continued disciplined growth
P&C | Continued disciplined growth
GWP & Other Revenues
[c. 30; p. 14]
GWP & Other Revenues
[Chart/image description:] A bar chart and table showing GWP & Other Revenues for FY24 and FY25, broken down by segment, with change metrics.
[c. 31; p. 14]
GWP & Other Revenues by segment
- Total GWP & Other Revenues: EUR 58.0bn in FY25 (+5% overall)
- Commercial lines: EUR 35.8bn
- AXA XL Reinsurance: EUR 2.6bn
- Retail lines: EUR 19.7bn
- Commercial lines GWP & Other Revenues change: +4% (o/w pricing +2%, o/w volume +2%)
- AXA XL Reinsurance GWP & Other Revenues change: +8% (o/w pricing +0.3%, o/w volume +7%)
- Retail lines GWP & Other Revenues change: +7% (o/w pricing +5%, o/w volume +2%)
- Continued pricing momentum and volume growth in Mid-market and SME
- Growth in lines of business with attractive margins, maintaining focus on retention at AXA XL Insurance
- Growth supported by alternative capital
- Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
[c. 32; p. 14]
GWP & Other Revenues
P&C| Delivering further margin expansion while enhancing reserve prudence
P&C | Delivering further margin expansion while enhancing reserve prudence
Combined ratio
[c. 33; p. 15]
Combined ratio
[Chart/image description:] Stacked bar chart comparing the Combined ratio for FY24 and FY25. - FY24 Total: 91.0% - FY25 Total: 90.6% The bars are composed of the following components: - Undiscounted CY loss ratio (ex Nat Cat): 67.4% in FY24; 67.0% in FY25. - Expense ratio: 25.0% in FY24; 24.8% in FY25. - Nat Cat: 3.8% in FY24; 3.4% in FY25. - Prior year reserve development: -1.6% in FY24; -1.1% in FY25. - Discount: -3.6% in FY24; -3.5% in FY25.
[c. 34; p. 15]
Undiscounted current year loss ratio
- Undiscounted current year loss ratio (excluding Nat Cat) improved due to margin expansion in Commercial lines SME & mid-market business and Personal lines, reflecting a favorable pricing environment.
- Stable AXA XL Insurance margins at attractive levels reflected disciplined cycle management.
- Improvement in expense ratio reflected the impact of efficiency measures, while continuing investment in growth initiatives and technology.
- Nat Cat charges were below the normalized load.
- Lower reliance on prior year reserve development.
- Enhanced reserve prudence.
P&C| Earnings growth from higher underwriting and financial result
P&C | Earnings growth from higher underwriting and financial result
[c. 35; p. 16]
P&C earnings growth
- All figures are in EUR million.
[c. 36; p. 16]
P&C | Earnings growth from higher underwriting and financial result
[Chart/image description:] The image shows a bridge chart for P&C Underlying Earnings from FY24 to FY25. - FY24: 5,510 (light blue bar) - Volume growth: +292 - Margin improvement: +189 - Underwriting result1: (bracket grouping Volume growth and Margin improvement) - Investment income: +435 - Insurance finance expenses: -235 - Financial result: (bracket grouping Investment income and Insurance finance expenses) - Tax: -169 - Affiliates, FX & other: -150 - FY25: 5,872 (dark blue bar) - Total change from FY24 to FY25: +9% (indicated by an arrow above the bridge)
[c. 37; p. 16]
P&C earnings drivers
- Better underwriting result from strong volume growth and improved all-year combined ratio, while enhancing reserve prudence
- Investment income increased due to higher volumes and better reinvestment yields on fixed income assets
- Higher unwind of discount of claims reserves, in line with guidance
- Unfavorable forex impact, notably due to USD depreciation vs. EUR
[c. 38; p. 16]
P&C | Earnings growth from higher underwriting and financial result
[c. 39; p. 17]
- Life & Health premiums and net flows are presented in EUR billion.
[c. 40; p. 17]
[Chart/image description:] Life GWP & Other Revenues bar chart: FY24 total 34.5, FY25 total 37.5 (+9%). FY24 breakdown: Protection 17.3 (+11%), Unit-linked 9.3 (+13%), Capital light G/A 9.0 (+7%), Traditional G/A 1.9 (-7%). FY25 breakdown: Protection 17.3, Unit-linked 9.3, Capital light G/A 9.0, Traditional G/A 1.9. Health GWP & Other Revenues bar chart: FY24 total 17.5, FY25 total 19.0 (+5%). FY24 breakdown: Individual 10.5 (+6%), Group 8.5 (+4%). FY25 breakdown: Individual 10.5, Group 8.5. Net flows bar chart: Protection +4.9, Health +2.7, Unit-Linked +1.5, Capital light G/A +1.2, Traditional G/A -5.0. Total net flows: €+5.4bn vs. €+1.5bn in FY24. Footnote below charts: o/w FY25 Employee Benefits¹ Euro 12.9 billion (+4% vs. FY24) Footnote 1: Including both short-term and long-term Employee Benefits GWP and other revenues.
[c. 41; p. 17]
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[c. 42; p. 18]
Life & Health Gross Written Premiums
- Gross Written Premiums (GWP) for Life & Health were EUR 3.8bn.
[c. 43; p. 18]
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[Chart/image description:] Bar chart showing PVEP (Present Value of Expected Premiums) comparison between FY24 and FY25. - Total FY24: 50.9 - Total FY25: 49.4 (-2% change) Breakdown of PVEP: - Protection & Health: FY25 is 31.4 (-4% change) - Unit-Linked: FY25 is 8.5 (+18% change) - Capital-light G/A: FY25 is 7.8 (-10% change) - Traditional G/A: FY25 is 1.7 (-10% change)
[c. 44; p. 18]
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[Chart/image description:] Bar chart showing NB CSM (pre-tax) comparison between FY24 and FY25. - FY24: 2.2 - FY25: 2.2 (+3% change)
[c. 45; p. 18]
Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting
[Chart/image description:] Bar chart showing NBV (post-tax) comparison between FY24 and FY25. - FY24: 2.3 - FY25: 2.2 (stable) NBV margin: - FY24: 4.4% - FY25: 4.5%
[c. 46; p. 18]
PVEP and NB CSM
- PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes.
- NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
[c. 47; p. 18]
NBV
- NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
Life & Health | Growth in new business driving Normalized CSM growth
Contractual Service Margin rollforward
[c. 48; p. 19]
Contractual Service Margin rollforward
[Chart/image description:] Waterfall bar chart showing Contractual Service Margin rollforward from FY24 to FY25. FY24 bar: 33.6. New business CSM: +2.2. Underlying return on in-force: +1.3. CSM release: -3.0. A dashed box groups these three bars labeled "Normalized CSM growth +2%". Economic variance: +0.6. Operating variance: -0.3. Affiliates, FX & other: -1.4. FY25 bar: 33.0. Below the chart: o/w Life FY24: 25.8, FY25: 25.4; o/w Health FY24: 7.7, FY25: 7.6. - **Normalized CSM up by +2%,** with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates - **Economic variance** reflecting government spreads tightening and positive equity market returns - **Operating variance** driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland - **FX** impact mainly from JPY and HKD depreciation
[c. 49; p. 19]
Contractual Service Margin rollforward
[Chart/image description:] No additional chart content visible beyond what is described in P019_B04.
Life & Health | Strong momentum in both short-term and long-term business
[c. 50; p. 20]
Financial metrics currency
- All financial figures are presented in EUR million.
[c. 51; p. 20]
Life & Health | Strong momentum in both short-term and long-term business
[Chart/image description:] Waterfall chart showing the bridge of Underlying Earnings from FY24 to FY25. - FY24 Total: 3,323 - Short-term technical margin: 415 - Long-term result incl. CSM release: 2,680 - Financial result: 975 - Tax & others: -748 - Bridge steps: - Short-term technical margin: +60 - Long-term result incl. CSM release: +156 - Financial result: -11 - Tax, FX and others: -27 - FY25 Total: 3,501 (+7% change) - Short-term technical margin: 479 - Long-term result incl. CSM release: 2,804 - Financial result: 946 - Tax & others: -728
[c. 52; p. 20]
Life & Health technical margin
- Life technical margin: EUR 2.7bn in FY25 (+4% vs. FY24)
- Health technical margin: EUR 0.8bn in FY25 (+17% vs. FY24)
- All figures are in billions.
- Change at constant FX.
- Strong short-term technical margin reflects underwriting and claims initiatives.
- Initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn).
- Higher long-term results from an 8% increase in CSM release.
- CSM release increase reflects growth in reserve base, including from favorable equity market performance, and better margins.
Growth in net income reflecting higher earnings & the gain from the sale of AXA IM
[c. 53; p. 21]
Net income by business segment
| FY24 | FY25 | Change | |
|---|---|---|---|
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | - |
| Underlying earnings | 8.1 | 8.4 | +6% |
| Non-financial flows | -0.5 | +2.1 | |
| o/w capital gains from AXA IM disposal | - | +2.2 | |
| Financial flows (incl. RCG) | +0.3 | -0.7 | |
| Net income | 7.9 | 9.8 | +26% |
[c. 54; p. 21]
Net income drivers
- Insurance businesses showed strong performance.
- Holding cost was stable and is expected to remain at the current level in 2026.
- Net income was higher, mainly reflecting higher underlying earnings and the gain from the sale of AXA IM.
- Financial flows were lower, reflecting an unfavorable forex impact.
[c. 55; p. 21]
Currency basis
- All figures are presented in Euro.
[c. 56; p. 21]
[Chart/image description:] Bar chart showing Underlying earnings per share in Euro. FY24 bar (light blue): 3.59. FY25 bar (dark navy): 3.86. A bracket above indicates +8% overall change between FY24 and FY25.
[c. 57; p. 21]
- Underlying earnings per share growth was +6% from earnings growth.
- Underlying earnings per share growth was +3% from capital management.
- Underlying earnings per share growth was -2% from forex.
- Underlying earnings per share growth included -1% from temporary earnings dilution due to the timing of the anti-dilutive share buyback related to the AXA IM sale.
[c. 58; p. 21]
[Chart/image description:] Dashed-border callout box reiterating the note about -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback.
[c. 59; p. 22]
- Shareholders' Equity in Euro billion.
[c. 60; p. 22]
[Chart/image description:] The image shows a bar chart and key metrics for Shareholders' equity1. The bar chart has three columns representing FY24, HY25, and FY25. - FY24: Total Shareholders' equity is 49.9. This is composed of SHE (excl. OCI) of 58.0 and Net OCI of -8.1. - HY25: Total Shareholders' equity is 45.5. This is composed of SHE (excl. OCI) of 52.7 and Net OCI of -7.2. - FY25: Total Shareholders' equity is 47.2. This is composed of SHE (excl. OCI) of 54.0 and Net OCI of -6.8.
[c. 61; p. 22]
Key financial metrics
- SHE (excl. OCI & undated subordinated debt): EUR 53.2bn in FY24; EUR 47.0bn in HY25; EUR 49.4bn in FY25
- Debt gearing: 20.6% in FY24; 23.4% in HY25; 22.3% in FY25
- Underlying ROE: 15.2% in FY24; 17.5% in HY25; 16.0% in FY25
[c. 62; p. 22]
| FY24 to FY25 | HY25 to FY25 | |
|---|---|---|
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | 1.3 | 0.4 |
| Net income for the period | 9.8 | 5.9 |
| Dividend | -4.6 | - |
| Annual share buyback | -1.2 | - |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 | -3.5 |
| Undated subordinated debt (including interest charges) | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | 0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |
Higher organic cash remittance and robust cash position at Holding
Net Cash Remittance
[c. 63; p. 23]
Net Cash Remittance
[Chart/image description:] Bar chart showing Net Cash Remittance for FY24 and FY25. - FY24 total is 7.7, consisting of: - 7.1 (light blue bar) - 0.6 (patterned bar at the top, labeled "Proceeds related to in-force treaties²") - FY25 total is 7.5 (dark blue bar) - Below the bars, "Remittance ratio¹" is shown: - FY24: 82% (grey oval) - FY25: 82% (dark blue oval)
[c. 64; p. 23]
Net Cash Remittance
| FY24 Cash position | 4.0 |
| Net cash remittance from subsidiaries | +7.5 |
| Dividend | -4.6 |
| Annual share buyback | -1.2 |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 |
| Holding costs and interest expenses | -1.3 |
| Change in net debt | +1.6 |
| M&A and other | +3.1 |
| FY25 Cash position | 5.6 |
Solvency II at 224%
[c. 65; p. 24]
Solvency II at 224%
[Chart/image description:] Left column: Three stacked bar charts titled "Solvency II at 224%" with unit "In Euro billion". Top chart: "Eligible Own Funds (EOF)". FY24 bar at 55.9, FY25 bar at 56.4. Between them, a waterfall of changes: +0.2, +8.8, -0.4, -2.1, -6.0, -0.1. A note above the -6.0 bar reads: "Foreseeable dividends: €4.8bn Provision for annual share buyback for 2026: €1.25bn". Middle chart: "Solvency II ratio". FY24 value 216%, FY25 value 224%. Between them, a flow of changes: +0pt (Regulatory & model changes), +28pts (Normalized capital generation), -1pt (Operating variance), +4pts (Economic variance & FX), -24pts (Dividend & annual share buyback), +2pts (Management actions, debt & other). Bottom chart: "Solvency Capital Requirement (SCR)". FY24 bar at 25.9, FY25 bar at 25.2. Between them, a waterfall: 0.0, +0.6, 0.0, -1.2, 0.0, -0.2.
Key sensitivities
[c. 66; p. 24]
Key sensitivities
[Chart/image description:] Right column: Horizontal bar chart titled "Key sensitivities". Subtitle: "Ratio as of December 31, 2025" with value 224% shown in a dark blue bar. Bars (left to right, light blue): - Interest rate +50bps: +2 pts - Interest rate -50bps: -1 pt - Corporate spreads +50bps: -1 pt - Euro Sovereign spreads +50bps1: -7 pts - Credit migration2: -4 pts - Listed Equity (excl. PE & Infra) +25%: -1 pt - Listed Equity (excl. PE & Infra) -25%: +2 pts - PE & Infra +25%: +14 pts - PE & Infra -25%: -19 pts - Inflation swap curve +50bps: -5 pts
[c. 67; p. 24]
Key sensitivities
Solvency II – impact of the end of grandfathering period and Solvency II revision
[c. 68; p. 25]
Solvency II – impact of the end of grandfathering period and Solvency II revision
[Chart/image description:] A visual representation of Solvency II ratio impacts: - Ratio as of 31/12/2025: represented by a dark blue bar, showing 224% - Impact of the end of grandfathering period on January 1, 2026: represented by a light blue bar, showing -10pts to 215% - Impact of Solvency II revision to come into effect in 1Q27: represented by a light blue bar, showing +17pts
[c. 69; p. 25]
Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision
| Ratio as of 31/12/2025 | 224% | |
| Impact of the end of grandfathering period on January 1, 2026 | -10pts to 215% | ▶ Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026 |
| Impact of Solvency II revision to come into effect in 1Q27 | +17pts1 |
▶ No change expected in organic capital generation
▶ Additional capital flexibility
Thomas Buberl, Group CEO Conclusion
Conclusion
[c. 70; p. 26]
Group CEO statement
- Thomas Buberl is the Group CEO.
Conclusion
[c. 71; p. 27]
Business performance and outlook
- Record results achieved at the top end of the target range, while enhancing reserve prudence.
- All businesses are in excellent shape, delivering strong growth and profitability.
- The diversified franchise is well-positioned to capture future growth opportunities.
- Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth.
February 26, 2026 Q&A Full Year 2025 Earnings
Q&A
Full Year 2025 Earnings
AXA Investor Relations | Keep in touch
[c. 72; p. 29]
AXA Investor Relations | Keep in touch
[Chart/image description:] Icon of a person/headset representing "Meet our management"
[c. 73; p. 29]
AXA Investor Relations | Keep in touch
[Chart/image description:] Handshake icon next to the "Meet our management" heading.
[c. 74; p. 29]
AXA Investor Relations | Keep in touch
| March | Roadshows | Europe and US |
|---|
May 51Q25 Activity IndicatorsParis June 2BNP Paribas Exane CEO ConferenceParis June 2-4Goldman Sachs European Financials ConferenceZurich July 31HY26 Earnings ReleaseParis September 21AXA Investor DayLondon
[c. 75; p. 29]
Investor Relations contact information
- Investor Relations contact number: +33 1 40 75 48 42
- Investor Relations email: investor.relations@axa.com
Follow us
[c. 76; p. 29]
Follow us
[Chart/image description:] www.axa.com link next to "Follow us" heading.
[c. 77; p. 29]
Follow us
[Chart/image description:] YouTube icon.
[c. 78; p. 29]
Follow us
- Follow AXA on Twitter: @AXA.
- Follow AXA on LinkedIn: AXA.
- Follow AXA on Instagram: @AXA.
- Follow AXA on YouTube: AXA.
[c. 79; p. 29]
Follow us
[Chart/image description:] Instagram icon.
[c. 80; p. 29]
Follow us
[Chart/image description:] Twitter/X icon.
[c. 81; p. 29]
Follow us
- Follow AXA on LinkedIn, X, Instagram, and YouTube.
- Visit AXA's website at axa.com.
[c. 82; p. 29]
Follow us
[Chart/image description:] Sustainability/leaf icon.
[c. 83; p. 29]
Follow us
- "O"
[c. 84; p. 29]
Follow us
[Chart/image description:] Additional social/web icon.
[c. 85; p. 29]
Follow us
[Chart/image description:] Additional icon.
[c. 86; p. 29]
Follow us
[Chart/image description:] Additional icon.
[c. 87; p. 30]
Follow us
[Chart/image description:] The image is a section divider page with a dark blue background. In the top left corner is the AXA logo, which consists of the word "AXA" in white within a white-outlined square, with a red diagonal slash through the top right corner of the square. The background features large, diagonal, translucent bands of purple and magenta. In the center of the page, the word "Appendices" is written in large, white, sans-serif font with a slight drop shadow. To the left of the word "Appendices" is a solid red diagonal parallelogram.
Appendices
[c. 88; p. 31]
Additional P&C disclosures
| 1. | Debt and Invested Assets | p.31 |
| 2. | Additional P&C disclosures | p.36 |
| 3. | Additional IFRS17 disclosures | p.41 |
| 4. | Sustainability | p.44 |
Gross financial debt and maturity breakdown as of December 31 st , 2025
Gross financial debt and maturity breakdown as of December 31st, 2025
Gross financial debt
[c. 89; p. 32]
Gross financial debt
[Chart/image description:] The chart displays "Gross financial debt" with two vertical bar stacks labeled "FY24" and "FY25", and a third labeled "Jan 1st 2026 End of the grandfathering period". Each bar is segmented into three tiers: Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The FY24 bar totals 19.2, with segments 3.5 (Senior), 10.8 (Tier 2), and 4.8 (Tier 1). The FY25 bar totals 20.3, with segments 3.5 (Senior), 12.2 (Tier 2), and 4.6 (Tier 1). The Jan 1st 2026 bar totals 20.3, with segments 5.8 (Senior), 11.3 (Tier 2), and 3.2 (Tier 1). A note in a dashed box points to the Jan 1st 2026 bar, stating "o/w €0.4bn redeemed in Jan 2026". Above the FY24 and FY25 bars, two ovals show "Debt gearing" percentages: 20.6% for FY24 and 22.3% for FY25. A legend at the bottom identifies the colors: dark blue for Tier 1, medium blue for Tier 2, and light blue for Senior debt.
Contractual maturity breakdown
[c. 90; p. 32]
Contractual maturity breakdown
[Chart/image description:] This bar chart shows debt maturity by year from 2025 to ≥2040 and "Undated", broken down by Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The total for each year is shown above the stacked bars. 2025: 0.5 (all Senior). 2026: 0.7 (all Tier 2). 2027: 0.9 (all Tier 2). 2028: 1.5 (all Senior). 2029: 0.7 (all Tier 2). 2030: 0.9 (all Tier 2). 2031-2039: 1.5 (all Senior). ≥2040: 0.5 (all Senior). Undated: 0.7 (all Tier 2) and 4.6 (all Tier 1). Below the main chart, a section titled "o/w Grandfathered debt" shows two rows for Tier 1 and Tier 2, with dashed boxes for each year. Tier 1: 1.4 in "Undated". Tier 2: 0.7 in 2029, 0.2 in ≥2040. A legend on the right identifies the colors.
Economic maturity breakdown
[c. 91; p. 32]
Economic maturity breakdown
[Chart/image description:] This bar chart shows economic maturity by year from 2025 to ≥2040 and "Undated", broken down by Senior debt (light blue), Tier 2 (medium blue), and Tier 1 (dark blue). The total for each year is shown above the stacked bars. 2025: 0.1 (all Tier 2). 2026: 2.4 (all Tier 2). 2027: 0.1 (all Tier 1) and 0.5 (all Tier 2). 2028: 2.0 (all Tier 2). 2029: 0.7 (all Tier 2). 2030: 0.9 (all Tier 2). 2031-2039: 1.5 (all Senior) and 6.4 (all Tier 2). ≥2040: 0.5 (all Senior). Undated: 0.7 (all Tier 2) and 4.0 (all Tier 1). Below the main chart, a section titled "o/w Grandfathered debt" shows two rows for Tier 1 and Tier 2, with dashed boxes for each year. Tier 1: 0.1 in 2026, 0.1 in 2028, 0.4 in 2031-2039, 0.8 in "Undated". Tier 2: 0.7 in 2029, 0.2 in ≥2040. A legend on the right identifies the colors.
[c. 92; p. 32]
Economic maturity breakdown
General Account Invested Assets
[c. 93; p. 33]
General Account Invested Assets
[Chart/image description:] A donut chart showing the breakdown of FY25 Total General Account invested assets. The center of the donut chart reads: Euro 450 billion
[c. 94; p. 33]
FY25 General Account Invested Assets Composition
- Duration gap for General Account invested assets was -0.4 years.
- Total General Account invested assets composition:
- Fixed income: ~77%
- Real estate: ~9%
- Private equity and hedge funds: ~5%
- Cash: ~4%
- Infrastructure equity: ~2%
- Listed equities: ~2%
- Policy loans: ~0%
[c. 95; p. 33]
Invested assets (100%)
In Euro billion
| FY25 | % | |
|---|---|---|
| Fixed income | 345 | 77% |
| o/w Government bonds | 167 | 37% |
| o/w Corporate bonds and loans | 121 | 27% |
| o/w Other fixed income 1 | 56 | 13% |
| Real estate | 41 | 9% |
| Infrastructure equity | 10 | 2% |
| Listed equities 2 | 10 | 2% |
| Private equity and hedge funds 3 | 23 | 5% |
| Cash | 19 | 4% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets 4 | 450 | 100% |
Structured and Private Credit assets
[c. 96; p. 34]
Structured and Private Credit assets
| Invested assets (100%) In Euro billion |
FY25 | % of total G/A1 portfolio |
Comments |
|---|---|---|---|
| Residential Mortgages | 16 | 4% | - €6bn Dutch mortgages, NHG guaranteed - €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
| CLO & ABS | 25 | 6% | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
| Infrastructure debt | 8 | 2% | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
| CRE debt | 8 | 2% | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
| Mid-Market lending | 10 | 2% | - Strong diversification with €8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
| Other | 2 | 0% | |
| Total Structured and Private Credit Assets | 69 | 15% | o/w 54% participating |
Investment portfolio | Fixed Income reinvestment
FY25 Fixed Income Reinvestment
[c. 97; p. 35]
FY25 Fixed Income Reinvestment
[Chart/image description: ] A donut chart showing the breakdown of FY25 Fixed Income Reinvestment, totaling Euro 57 billion.
- Government bonds & related (dark blue): 32%
- Investment grade credit (medium blue): 40%
- ABS/CLO/IG fund financing (light blue-grey): 21%
- Below investment grade credit (lightest blue): 7%
[c. 98; p. 35]
FY25 fixed income reinvestment allocation
- Government bonds & related: 32% of allocation, with an average rating of AA.
- Investment grade credit: 40% of allocation, with an average rating of A.
- ABS/CLO/IG fund financing: 21% of allocation.
- Below investment grade credit: 7% of allocation.
FY25 Fixed Income Reinvestment Yield
[c. 99; p. 35]
FY25 Fixed Income Reinvestment Yield
[Chart/image description: ] A bar chart showing reinvestment yields:
- Public fixed income: 3.5%
- Private & Structured fixed income: 4.7%
- Total fixed income: 3.9%
▶ Euro 57 billion fixed income invested at 3.9%
[c. 100; p. 35]
Fixed income portfolio characteristics
- Average duration of 9 years
- EUR 19.7bn of Private & Structured Credit invested at 4.7%
- Private & Structured Credit includes CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY
- Gradual shift from alternative total return assets to Private & Structured credit
[c. 101; p. 35]
▶ Euro 57 billion fixed income invested at 3.9%
[c. 102; p. 36]
Debt and invested assets
| 1. | Debt and Invested Assets | p.31 |
| 2. | Additional P&C disclosures | p.36 |
| 3. | Additional IFRS17 disclosures | p.41 |
| 4. | Sustainability | p.44 |
AXA XL Insurance | Large Commercial & Specialty business
[c. 103; p. 37]
Business diversification
- AXA XL Insurance is well diversified across lines of business and geographies.
- AXA XL Insurance holds leading market positions across its lines of business.
[c. 104; p. 37]
AXA XL Insurance | Large Commercial & Specialty business
[Chart/image description:] Left column: Two donut charts. Top chart: Title "FY25 GWP by line of business", center value "$19bn". Segments: Casualty (35%), Property (29%), Specialty (19%), Professional lines¹ (17%). Bottom chart: Title "FY25 GWP by geography", center value "$19bn". Segments: Americas (46%), Europe & APAC (35%), UK & Lloyds (19%).
[c. 105; p. 37]
AXA XL Insurance market positions
- AXA XL Insurance holds leading market positions across lines, ranking in the top 3 globally for Multinational Programs, Marine, and Fine Art & Specie.
[c. 106; p. 37]
AXA XL Insurance profitability vs. ex-price growth
- A scatter plot illustrates profitability versus ex-price growth for various lines of business.
- Property shows high profitability and high ex-price growth.
- Specialty shows moderate profitability and moderate ex-price growth.
- Casualty shows moderate profitability and low ex-price growth.
- Professional lines shows low profitability and low ex-price growth.
Top 3 globally
[c. 107; p. 37]
Global P&C Commercial Lines
- AXA XL is a global leader in P&C Commercial Lines.
- AXA XL is the #1 global insurer for Multinational Programs.
- AXA XL is the #1 global insurer for Marine.
- AXA XL is the #1 global insurer for Fine Art & Specie.
Managing the cycle to deliver consistent profitability
[c. 108; p. 37]
profitability ex-price growth
- Profitability Ex-price growth: 0.5% in 2023; 0.5% in 2022; 0.5% in 2021; 0.5% in 2020; 0.5% in 2019
[c. 109; p. 37]
Managing the cycle to deliver consistent profitability
[Chart/image description:] Scatter plot with Y-axis labeled "Profitability" and X-axis labeled "Ex-price growth (%)". Four bubbles: "Property" (high profitability, high ex-price growth), "Specialty" (medium-high profitability, medium ex-price growth), "Casualty" (medium profitability, low ex-price growth), "Professional lines" (low profitability, very low ex-price growth).
[c. 110; p. 37]
Managing the cycle to deliver consistent profitability
P&C | Focus on Reserves
Claims reserves ratio
[c. 111; p. 38]
Claims reserves ratio definition
- The claims reserves ratio is calculated as Net undiscounted claims reserves divided by Net earned premiums.
[c. 112; p. 38]
Claims reserves ratio
[Chart/image description:] Bar chart showing Claims reserves ratio for FY18 to FY25. - IFRS4 period (light blue bars): - FY18: 179% - FY19: 185% - FY20: 193% - FY21: 188% - FY22: 189% - IFRS17 period (dark blue bars): - FY22: 198% - FY23: 195% - FY24: 180% - FY25: 175%
Technical reserves ratio
[c. 113; p. 38]
Net undiscounted technical reserves ratio
- Net undiscounted technical reserves are presented as a ratio to Net earned premiums.
[c. 114; p. 38]
Technical reserves ratio
[Chart/image description:] Bar chart showing Technical reserves ratio for FY18 to FY25. - IFRS4 period (light blue bars): - FY18: 213% - FY19: 227% - FY20: 233% - FY21: 226% - FY22: 227% - IFRS17 period (dark blue bars): - FY22: 234% - FY23: 232% - FY24: 216% - FY25: 210%
[c. 115; p. 38]
Technical reserves ratio
P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1
P&C | 2026 Simplified Group Nat Cat Reinsurance Program
[c. 116; p. 39]
Currency
- All figures are in EUR.
[c. 117; p. 39]
P&C | 2026 Simplified Group Nat Cat Reinsurance Program
[Chart/image description:] Bar chart showing the 2026 Simplified Group Nat Cat Reinsurance Program. Two sections are shown: "Insurance segment (occurrence protection)" on the left, and "Reinsurance segment (illustrative)" on the right.
[c. 118; p. 39]
Insurance segment peril categories
- The Insurance segment includes six peril categories with specified Capacity and Retention levels:
- EU Windstorm: Capacity EUR 4.0bn; Retention EUR 600m
- Europe Flood: Capacity EUR 2.1bn; Retention EUR 450m
- Europe Earthquake: Capacity EUR 2.1bn; Retention EUR 400m
- NA Hurricane: Capacity EUR 1.2bn; Retention EUR 600m
- NA Earthquake: Capacity EUR 1.2bn; Retention EUR 600m
- Per other perils: Capacity ~EUR 0.8bn; Retention EUR 400m
[c. 119; p. 39]
Reinsurance segment and retention levels
- The Reinsurance segment includes "Alternative Capital & Cat Bonds".
- This segment has a value of EUR 1.0bn.
- Retention levels are expected to remain stable in 2026 compared to 2025.
[c. 120; p. 39]
P&C | 2026 Simplified Group Nat Cat Reinsurance Program
P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026
[c. 121; p. 40]
Group underlying earnings deviation to average Nat Cat charges
- Group underlying earnings deviation to average Nat Cat charges in 2026, net of reinsurance and post-tax, shows a median (50th percentile) of EUR 0bn.
- More severe years (negative deviation in approximately 40% of cases) include:
- 1/20y (95th percentile): EUR -1.2bn deviation.
- 1/10y (90th percentile): EUR -0.8bn deviation.
- 1/5y (80th percentile): EUR -0.4bn deviation.
- Less severe years (positive deviation in approximately 60% of cases) include:
- 1/5y (20th percentile): EUR +0.1bn deviation.
- 1/10y (10th percentile): EUR +0.5bn deviation.
- 1/20y (5th percentile): EUR +0.7bn and EUR +0.8bn deviation.
[c. 122; p. 40]
Average expected Nat Cat charges
- Average Expected Nat Cat charges net of reinsurance, pre-tax, are EUR 2.6bn for 2025 and EUR 2.7bn for 2026.
- The estimated impact on GEP for both 2025 and 2026 is approximately 4.5%.
- Natural catastrophe cost is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance.
- Deviation is compared to a normalized level, which represents costs associated with natural catastrophes expected in an average year (approximately 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
[c. 123; p. 41]
Additional P&C disclosures
| 1. | Debt and Invested Assets | p.31 |
| 2. | Additional P&C disclosures | p.36 |
| 3. | Additional IFRS17 disclosures | p.41 |
| 4. | Sustainability | p.44 |
P&C | Margin Analysis
[c. 124; p. 42]
P&C | Margin Analysis
[Chart/image description:] The image displays a financial margin analysis diagram for Property & Casualty (P&C) insurance, structured as a flow from "Technical Result" to "Financial Result" and finally to "Underlying Earnings before tax" and "Underlying Earnings". The entire diagram is labeled "In Euro million (pre-tax)".
[c. 125; p. 42]
P&C technical result components
- Technical Result components:
- Current Accident Year Undiscounted Technical Margin: EUR 2,778 (FY25); +EUR 707 change.
- Gross Earned Premiums: EUR 57,656 (+6%).
- Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt).
- Nat Cats within Combined Ratio: 3.4% (-0.4pt).
- Current Accident Year Discounting: EUR 2,009 (FY25); +EUR 115 change.
- Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt).
- Current Accident Year Net Claims reserves: EUR 19.0bn.
- Duration: 4.0 years.
- Current Accident Year Discount rate: 2.8%.
- Prior Years' Reserve Development (PYD): EUR 622 (FY25); -EUR 341 change.
- PYD ratio: -1.1% (+0.7pt).
- Current Accident Year Undiscounted Technical Margin: EUR 2,778 (FY25); +EUR 707 change.
- Sensitivity of FY25 Current Accident Year discount rate changes: +25bps leads to +EUR 0.2bn; -25bps leads to -EUR 0.2bn.
- This sensitivity refers to a parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.
[c. 126; p. 42]
P&C financial result components
- Financial Result components:
- 2026e Insurance Finance Expenses (pre-tax): ~EUR -1.4bn.
- Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount: +25bps leads to ~EUR -50m; -25bps leads to ~+EUR 50m.
[c. 127; p. 42]
P&C underlying earnings
- Underlying Earnings before tax (FY25): EUR 8,040; +EUR 681 change.
- Tax: -EUR 2,060; -EUR 169 change.
- Affiliates, Minority interests & Other: -EUR 108; -EUR 10 change.
- Underlying Earnings (FY25): EUR 5,872; +EUR 501 change.
- Growth vs. FY24 (at constant FX): +9%.
- The diagram uses dashed lines and plus signs (+) to indicate summation between components.
L&H | Margin Analysis
[c. 128; p. 43]
Scope impact
- Includes scope impact.
[c. 129; p. 43]
L&H | Margin Analysis
[Chart/image description:] Flowchart showing the components of Life & Health Margin Analysis, leading to Underlying Earnings.
[c. 130; p. 43]
Technical and Financial Results
- Short-term Technical Margin: EUR 479m (change: +EUR 60m)
- Gross Earned Premiums: EUR 17,416m (change: +10%)
- All Year Combined Ratio: 97.2% (change: -0.1pts); includes recapture of Laya
- Long-term Technical Margin: EUR 2,804m (change: +EUR 156m)
- CSM release: EUR 2,954m (change: +EUR 215m)
- Technical experience: -EUR 150m (change: -EUR 58m)
- Investment Income (non-VFA only): EUR 2,484m (change: -EUR 1m)
- FY25 Average Assets: EUR 98bn
- Asset book yield: 2.5%
- FY25 Reinvestment yield: 3.8%
- Insurance Finance Expenses (non-VFA only): -EUR 1,538m (change: -EUR 9m)
- FY24 Reserves at locked-in rate: EUR 62bn
- Liability book yield: 2.5%
[c. 131; p. 43]
Underlying Earnings
- Underlying Earnings before tax: EUR 4,229m (change: +EUR 205m)
- Tax: -EUR 800m (change: +EUR 65m)
- Affiliates, Minority interests & Other: EUR 72m (change: -EUR 51m)
- Underlying Earnings: EUR 3,501m (change: +EUR 219m)
- Underlying Earnings growth vs. FY24 (at constant FX): +7%
[c. 132; p. 43]
Life & Health FY25 CSM by sensitivities
| Baseline | 33.3 |
| Interest rates +50bps | -0.8 |
| Interest rates -50bps | 0.6 |
| Sovereign spreads +50bps | -1.9 |
| Sovereign spreads -50bps | 1.9 |
| Corporate spread +50bps | -0.8 |
| Corporate spread -50bps | 0.7 |
| Equities +25% | 1.8 |
| Equities -25% | -2.2 |
Table of contents
[c. 133; p. 44]
Table of contents
| 1. | Debt and Invested Assets | p.31 |
| 2. | Additional P&C disclosures | p.36 |
| 3. | Additional IFRS17 disclosures | p.41 |
| 4. | Sustainability | p.44 |
Expanding AXA's role in society: AXA for Progress Index 1
Expanding AXA’s role in society: AXA for Progress Index
[c. 134; p. 45]
Climate transition financing and community resilience financing by target and result
| Target | 2025 Result |
|---|---|
€5bn2
in climate transition financing per year
€6.4bn
>€500m2
in community resilience financing per year
€1.4bn
[c. 135; p. 45]
Target by 2025 Result
| Target | 2025 Result |
|---|---|
€6bn3
in P&C GWP to support transition underwriting (cumulative 2024-2026)
€4.6bn
>20,0004
climate adaptation solutions & services (cumulative 2024-2026)
Target revised in 2025
19,698
Cumulative 2024-2025
>20m5(footnote: 5. Low-income to mass market segments in emerging markets and modest income segments in mature markets.)
inclusive insurance customers by 2026
20.6m
[c. 136; p. 45]
Target by 2025 Result
| Target | 2025 Result |
|---|---|
>80,0006(footnote: 6. Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.)
AXA Group employees trained on climate adaptation by 2026
46,420
Contribute to Net-Zero
-50%7(footnote: 7. Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.) by 2030
in absolute carbon emissions and offset of residual emissions8(footnote: 8. Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).)
-64%
Reduction against 2019
50%
Percentage of AXA Group employees engaged in volunteering activities by 2026
56%
Sustainability Performance & Ratings
S&P Global
[c. 137; p. 46]
Dow Jones Best-in-Class indices
- AXA achieved the 97th percentile in the Dow Jones Best-in-Class Europe & World indices for 2025.
[c. 138; p. 46]
S&P Global
[Chart/image description:] Logo of MSCI.
[c. 139; p. 46]
S&P Global rating
- 2025 score: AAA
[c. 140; p. 46]
S&P Global
[Chart/image description:] Logo of Morningstar Sustainalytics.
[c. 141; p. 46]
ESG Risk Rating
- 2025 ESG Risk Rating: 17.0 (Low risk)
[c. 142; p. 46]
S&P Global
[Chart/image description:] Logo of FTSE Russell, An LSEG Business.
[c. 143; p. 46]
FTSE4Good Index Series Score
- AXA's 2025 score in the FTSE4Good Index Series is 4.3/5.
QCDP
[c. 144; p. 46]
CDP score
- CDP 2025 score: B
[c. 145; p. 46]
QCDP
Scope
[c. 146; p. 47]
Scope
Theme: Scope definitions
Glossary
[c. 147; p. 48]
Glossary of financial terms
- Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
- Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders.
- CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
- Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
- Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow.
- Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
- Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities).
- New Business Value (NBV): the value of newly issued contracts during the current year. It consists of the sum of:
- the new business contractual service margin.
- the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals.
- the present value of the future profits of pure investment contracts accounted for under IFRS 9.
- net of the cost of reinsurance.
- taxes.
- minority interests.
- New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
- New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP.
- Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance.
- Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share.
- Technical experience: consists of the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
- Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.
February 26, 2026 Thank you Full Year 2025 Earnings
[c. 148; p. 49]
Thank you
- Thank you
- Full Year 2025 Earnings